rfhg_208055.1

Basic information about the TSS

---

TSS ID: rfhg_208055.1 Species: human Chr: chr19		Start: 12799976 End: 12799987 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000498785.1:-260 GeneID: 7001 HGNC/MGI_ID: HGNC:9353 UniProt_ID: Nearer transcript ids and distances: ENST00000478908.1:-474

Gene_name: peroxiredoxin 2 Gene_symbol: PRDX2 Gene_synonyms: MGC4104 NKEFB PRP PRX2 PRXII TSA Gene_source: HGNC:9353

TATA-Box annotation

---

Distance to TSS:	1819
Nearest PromoterID:	NM_005809
Entrez ID:	7001
Nearest Unigene:	Hs.432121
Nearest Refseq:	NM_005809
Nearest Ensembl:	ENSG00000167815
Gene Name:	peroxiredoxin 2
Gene Alias:	HEL-S-2a|NKEF-B|NKEFB|PRP|PRX2|PRXII|PTX1|TDPX1|TPX1|TSA
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.416667
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PRDX2 p2@PRDX2 p3@PRDX2 p4@PRDX2 p5@PRDX2 p7@PRDX2
Sample		p1@PRDX2	p2@PRDX2	p3@PRDX2	p4@PRDX2	p5@PRDX2	p7@PRDX2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	272.72	43.44	49.87	10.91	0.58	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	257.75	46.74	41.68	14.16	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	268.72	40.32	54.98	11.19	0.39	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	243.05	35.76	44.08	9.36	1.66	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	253.99	39.14	44.09	13.27	2.47	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	274.82	40.12	51.36	9.11	0.58	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	464.53	52.29	63.62	22.44	2.83	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	351.22	45.05	54.26	14.78	1.94	1.45
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	338.31	45.95	62.41	14.53	1.28	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	260.25	18.55	45.21	12.75	1.16	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	250.63	23.04	46.08	17.38	2.02	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	239.05	23.99	37.81	8.13	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	88.01	34.17	29.82	10.32	1.77	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	90.06	30.82	36.38	10.07	0.90	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	73.11	27.66	27.01	7.68	0.66	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	90.03	27.92	31.94	10.06	2.77	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	88.24	27.52	30.14	10.92	1.53	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	83.52	26.15	26.15	14.76	2.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	85.30	23.99	33.06	11.20	3.73	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	102.75	29.94	30.09	9.48	1.20	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	86.07	28.47	29.94	8.95	1.47	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	105.65	30.55	30.90	10.70	1.21	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	83.89	26.37	25.98	8.01	1.03	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	75.71	26.69	28.15	10.43	1.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	87.46	26.06	31.99	11.61	0.77	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	90.84	23.74	28.80	8.23	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	93.41	29.12	29.67	10.99	2.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	106.56	33.71	30.88	8.25	1.18	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	106.28	29.40	27.14	11.47	1.29	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	99.71	26.60	26.42	11.04	0.54	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	110.32	28.05	28.26	10.68	1.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	100.82	28.72	27.94	12.90	1.37	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	109.31	29.97	27.01	11.82	1.27	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	146.96	38.10	39.09	13.20	3.30	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	108.64	27.30	33.28	11.22	0.93	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	95.81	26.64	25.10	10.35	1.15	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	105.05	24.73	29.02	10.83	0.61	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	106.79	27.60	27.81	10.07	2.01	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	99.40	25.39	27.55	9.45	1.08	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	86.42	27.37	28.81	7.44	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	94.81	27.05	30.35	10.59	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	126.05	26.35	32.65	8.93	1.46	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	99.54	28.26	28.05	8.01	1.27	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	92.66	27.62	27.80	9.97	1.22	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	106.61	27.31	26.90	11.85	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	103.53	25.82	26.75	6.98	1.16	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	106.76	24.95	23.75	8.88	0.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	100.44	24.14	25.63	7.75	0.60	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	108.92	28.49	25.13	9.34	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	102.51	27.70	23.45	7.89	1.21	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	97.76	19.68	26.85	9.02	1.23	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	103.18	24.24	29.13	10.01	1.11	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	111.94	13.99	13.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	94.39	29.10	28.74	9.94	1.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	85.50	28.50	22.20	7.62	1.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	101.51	15.10	37.75	2.52	4.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	149.71	22.04	37.20	7.81	1.84	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	92.70	27.23	30.79	5.83	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	71.94	21.84	23.45	8.99	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	99.64	27.35	33.63	5.03	1.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	76.85	21.15	23.97	7.76	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	79.07	25.24	24.67	9.53	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	48.56	17.52	23.88	5.57	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	80.86	25.48	24.80	6.12	0.68	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	72.13	17.22	17.22	7.47	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	46.50	15.26	14.20	6.03	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	31.59	31.59	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	20.48	17.06	11.70	8.29	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	29.75	15.37	11.41	2.48	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	22.52	14.54	11.73	2.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	18.55	12.59	13.91	6.29	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	21.96	13.30	12.68	6.81	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	19.57	14.98	16.82	7.64	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	105.33	34.69	30.57	8.87	2.22	0.00
Adipocyte - breast, donor2	11327-117E4	213.21	21.66	25.35	6.26	0.48	0.80
Adipocyte - omental, donor1	11473-119C6	143.77	26.21	27.23	6.49	1.65	0.13
Adipocyte - omental, donor2	11474-119C7	120.35	14.95	17.94	4.48	1.49	0.75
Adipocyte - omental, donor3	11475-119C8	181.53	20.43	20.10	5.36	1.34	0.33
Adipocyte - perirenal, donor1	11476-119C9	100.16	21.05	19.78	10.21	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	130.84	20.89	28.59	6.60	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	83.55	23.48	19.42	3.16	4.97	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	186.98	30.41	24.33	7.65	1.91	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	63.95	28.36	16.04	6.06	0.20	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	54.31	13.90	13.90	4.63	0.26	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	57.43	18.68	13.10	6.97	0.56	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	96.40	24.10	24.10	7.05	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	510.35	32.90	34.43	7.56	1.69	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	143.95	12.91	17.75	4.84	0.00	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	110.37	10.66	20.79	4.27	1.07	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	278.22	15.58	19.48	6.12	1.11	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	521.94	26.20	33.27	9.15	0.83	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	223.54	21.10	23.61	4.02	0.50	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	319.72	17.34	20.94	5.24	1.31	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	342.53	9.44	21.31	3.04	0.61	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	204.86	40.22	36.91	8.62	0.44	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	278.62	45.54	46.97	14.34	0.36	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	142.56	50.32	35.94	11.98	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	77.36	34.54	17.45	10.07	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	58.57	45.18	35.14	13.39	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	86.08	38.42	31.84	10.68	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	169.35	43.60	44.05	15.10	0.11	0.46
Anulus Pulposus Cell, donor2	11463-119B5	124.17	24.74	23.27	7.59	0.49	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	105.14	29.65	26.06	6.29	0.00	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	134.15	36.90	24.31	9.55	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	89.89	27.82	25.68	14.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	108.81	29.89	22.42	6.88	0.30	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	150.49	31.62	30.35	6.32	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	103.63	23.10	37.62	9.90	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	120.21	25.34	24.37	7.47	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	110.20	41.26	33.01	7.77	1.94	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	113.43	32.07	49.29	8.31	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	123.16	31.26	30.13	8.66	0.75	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	116.83	28.30	26.85	11.61	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	95.29	25.08	33.85	13.79	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	160.29	40.20	43.82	9.39	0.33	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	124.20	23.20	20.47	4.09	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	117.01	28.80	30.01	7.09	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	107.16	32.68	20.90	8.04	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	111.85	24.94	29.10	9.26	0.57	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	121.35	22.18	32.88	6.95	1.34	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	97.55	21.46	32.19	7.80	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	117.43	30.19	29.69	9.62	0.17	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	104.46	21.61	39.62	8.41	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	95.58	14.16	31.86	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	116.30	25.73	26.07	7.89	0.17	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	96.48	20.97	50.34	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	117.96	35.44	26.70	13.59	0.97	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	122.56	30.36	31.49	10.62	0.38	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	112.66	24.23	42.40	6.06	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	111.16	38.76	31.35	6.84	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	123.78	29.71	30.78	9.62	0.21	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	109.17	30.20	35.10	9.81	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	119.65	27.21	30.97	7.04	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	109.65	27.65	28.30	9.32	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	117.01	29.25	32.11	8.56	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	111.14	28.66	18.13	9.94	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	118.92	21.68	28.00	10.54	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	92.66	33.26	41.58	14.26	2.38	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	110.87	37.12	33.56	8.14	0.51	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	109.52	27.25	27.00	6.62	0.76	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	108.65	31.77	31.77	12.07	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	109.18	32.37	31.07	10.79	0.43	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	122.99	26.04	25.61	8.26	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	120.92	20.88	28.71	10.15	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	108.64	21.73	34.01	4.72	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	105.95	31.19	27.12	8.98	0.00	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	92.65	16.21	41.69	13.90	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	105.63	25.35	14.79	10.56	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	116.21	26.37	27.23	10.08	0.21	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	120.93	27.07	36.70	12.03	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	107.16	34.99	19.68	5.83	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	117.93	27.59	28.28	10.11	0.69	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	94.36	20.40	38.25	5.10	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	129.15	30.00	33.81	7.12	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	128.41	29.31	32.82	10.12	0.21	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	105.88	28.76	33.05	9.18	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	112.81	32.03	27.72	6.69	0.48	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	109.54	28.60	25.94	8.65	0.22	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	135.80	22.89	41.20	9.15	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	122.96	32.13	26.03	4.98	1.11	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	113.07	22.24	25.95	10.33	0.53	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	100.31	28.35	29.80	13.81	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	227.58	45.44	39.79	21.00	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	151.82	45.02	27.73	16.09	0.17	0.17
Astrocyte - cerebellum, donor3	11661-122F5	130.88	50.55	34.40	16.15	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	219.96	69.72	71.46	17.78	0.35	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	198.33	50.64	56.62	15.37	0.65	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	183.77	55.94	53.10	15.81	0.30	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	77.64	37.16	27.18	9.06	0.34	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	71.16	34.70	23.80	8.39	0.13	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	75.22	27.88	23.90	7.62	0.23	0.00
Basophils, donor1	12241-129G9	9.42	4.97	4.18	1.31	0.00	0.00
Basophils, donor2	12242-129H1	33.91	10.46	10.10	4.69	0.00	0.00
Basophils, donor3	12243-129H2	12.49	6.03	5.14	1.76	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	150.06	29.75	30.62	5.82	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	235.91	37.95	47.09	10.06	1.37	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	129.12	28.69	14.35	0.00	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	134.32	11.30	14.44	4.39	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	145.36	25.16	23.50	8.32	0.42	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	118.83	23.95	18.42	5.76	0.92	1.15
Bronchial Epithelial Cell, donor7	11769-123I5	85.65	26.99	22.85	5.40	0.00	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	17.00	3.30	3.19	0.82	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	90.37	24.45	19.80	7.22	0.23	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	61.72	40.93	33.90	11.83	0.32	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	20.68	0.00	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	11.27	5.07	4.51	1.13	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	7.98	3.34	5.57	0.74	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	12.95	6.15	4.17	1.10	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	5.38	4.53	2.26	1.42	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	14.40	6.82	7.20	1.90	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	9.86	4.60	6.90	1.97	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	5.20	2.89	3.04	0.87	0.14	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	6.03	0.91	1.81	0.91	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	3.32	0.71	2.13	0.47	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	5.36	1.84	3.52	0.67	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	6.07	1.38	2.76	1.10	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	4.96	0.50	1.49	0.50	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	6.66	2.94	3.72	0.98	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	8.55	3.38	5.34	1.78	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	6.53	1.09	1.31	0.44	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	3.98	2.58	2.11	0.94	0.00	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	8.45	2.64	4.22	1.06	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	4.44	1.11	2.22	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	5.80	1.78	3.72	0.59	0.30	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	8.38	3.39	4.19	1.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	3.33	0.62	2.91	0.21	0.21	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	7.32	3.20	5.26	0.69	0.69	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	9.27	2.26	2.26	0.45	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	1.75	0.44	1.75	0.44	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	6.19	2.42	3.23	0.27	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	8.55	4.19	4.36	2.09	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	2.95	2.10	0.84	0.42	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	5.51	2.76	4.23	0.73	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	7.75	2.11	3.52	1.06	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	2.63	0.88	0.44	0.88	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	5.93	3.66	3.84	1.22	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	4.83	2.60	2.97	0.74	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	6.04	1.29	5.17	1.08	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	15.15	2.05	3.28	0.41	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	6.26	1.62	4.64	0.46	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	1.62	1.16	1.86	0.46	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	13.08	2.83	3.92	1.53	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	16.86	4.62	7.39	2.08	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	10.61	3.90	5.20	2.17	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	19.47	9.19	10.12	2.80	0.16	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	15.89	6.64	7.16	1.22	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	9.59	2.68	6.24	1.56	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	12.50	4.34	4.08	1.53	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	14.49	4.83	4.83	0.66	0.44	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	13.69	3.58	4.63	1.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	63.00	26.42	20.32	4.06	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	61.70	22.37	21.02	2.03	0.68	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	51.78	33.14	15.53	6.21	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	41.58	12.79	16.52	4.26	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	46.64	18.23	21.44	8.04	1.07	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	58.26	23.87	18.95	7.02	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	65.10	22.75	22.75	7.84	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	63.28	18.46	26.37	2.64	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	14.79	6.58	12.33	3.29	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	21.04	8.71	5.80	1.45	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	20.70	7.57	13.63	1.01	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	5438.21	122.83	284.46	15.76	7.27	3.23
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	5175.80	102.67	276.85	14.78	6.39	2.40
CD34+ Progenitors, donor1	11545-120B6	24.10	15.06	24.10	13.05	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	25.84	17.42	14.61	4.49	0.00	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	237.85	41.33	33.07	12.78	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	221.20	44.42	45.77	14.43	1.35	0.00
CD4+ T Cells, donor1	11225-116C1	71.77	16.78	15.71	2.86	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	67.36	11.63	27.56	4.90	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	80.82	17.69	23.18	3.66	0.30	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	186.58	25.52	42.37	4.59	1.02	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	168.90	31.22	45.82	7.64	0.22	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	151.78	24.72	42.54	6.61	1.72	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	150.29	22.76	45.04	7.11	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	175.58	32.31	49.86	4.92	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	154.92	23.07	69.22	9.89	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	157.38	24.71	40.03	5.78	0.58	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	153.87	25.25	31.18	5.93	1.02	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	134.61	20.96	33.37	6.61	0.81	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	97.28	17.93	27.35	8.07	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	120.89	22.71	41.93	7.34	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	107.80	11.88	33.00	7.04	1.32	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	235.70	23.19	52.28	7.17	1.69	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	140.87	24.93	38.44	5.82	0.62	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	157.04	24.06	39.76	12.36	0.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	127.81	23.66	48.13	8.43	0.27	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	113.09	19.83	47.16	5.90	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	127.32	17.93	52.00	5.38	0.00	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	230.12	28.56	48.95	8.16	0.74	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	175.03	30.76	47.87	6.72	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	149.21	30.89	44.76	9.25	0.63	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	125.90	23.76	42.47	9.10	2.02	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	122.61	29.89	43.76	5.63	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	95.01	12.20	33.99	2.61	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	150.44	31.67	43.05	12.37	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	110.78	25.85	43.39	3.69	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	153.54	29.31	58.62	12.56	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	130.16	22.71	36.00	7.20	0.28	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	124.90	25.28	34.11	10.80	0.25	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	157.08	16.94	41.58	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	127.49	32.95	44.76	9.31	0.72	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	120.49	41.55	51.24	15.23	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	44.53	17.68	16.04	3.60	0.33	0.00
CD8+ T Cells, donor2	11307-117C2	36.79	10.51	13.14	3.38	0.75	0.38
CD8+ T Cells, donor3	11383-118B6	57.82	12.88	23.73	5.30	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	126.17	18.58	24.09	5.05	0.23	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	126.05	17.01	18.69	5.03	0.48	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	140.63	16.69	25.44	5.20	0.00	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	178.93	31.82	36.03	6.00	0.00	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	136.79	18.72	22.80	10.56	0.48	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	126.88	13.19	23.19	5.23	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	151.88	22.60	25.42	4.56	0.43	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	162.66	23.16	26.32	6.05	1.05	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	146.57	22.04	26.73	5.86	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	223.09	33.51	35.62	8.75	0.60	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	215.55	31.66	39.22	9.30	0.58	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	211.82	32.77	34.90	7.99	0.53	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	100.68	15.76	14.01	4.82	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	117.96	19.58	18.67	2.28	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	87.27	17.16	19.39	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	132.90	18.37	25.21	6.12	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	128.61	20.72	22.15	6.33	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	130.58	17.91	18.15	4.95	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	143.24	25.04	23.45	5.70	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	138.71	30.45	22.76	6.15	0.62	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	126.95	18.27	23.72	5.45	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	160.64	22.95	28.68	7.27	1.15	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	150.94	26.80	26.41	7.09	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	152.80	21.94	15.88	2.27	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	72.27	10.44	15.26	4.82	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	88.13	9.79	19.58	1.40	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	89.16	24.04	19.03	2.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	38.38	12.79	14.62	5.48	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	106.23	31.62	27.17	10.87	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	82.50	51.56	30.62	10.94	0.11	0.11
Chondrocyte - de diff, donor1	11261-116G1	66.56	13.87	7.63	5.20	0.69	0.00
Chondrocyte - de diff, donor2	11338-117F6	87.78	26.30	22.03	5.69	1.07	0.00
Chondrocyte - de diff, donor3	11410-118E6	88.18	26.97	21.96	7.74	0.57	0.00
Chondrocyte - re diff, donor2	11339-117F7	100.27	21.49	20.59	4.48	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	70.37	29.93	21.03	6.47	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	187.63	59.56	54.51	17.10	0.34	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	125.69	35.49	45.10	12.18	0.64	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	145.76	47.08	34.96	14.25	0.27	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	111.23	29.34	29.89	8.34	0.37	0.09
Corneal Epithelial Cells, donor1	11526-119I5	157.87	42.60	35.79	9.66	0.66	0.00
Corneal Epithelial Cells, donor2	11606-120I4	242.31	29.58	40.95	7.96	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	166.93	41.16	31.70	8.18	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	39.29	15.52	8.58	4.29	0.17	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	42.26	18.92	9.15	3.15	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	37.96	24.15	6.90	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	22.14	12.31	9.29	3.67	0.22	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	11.62	11.27	7.86	3.76	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	13.71	11.75	5.88	3.92	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	12.58	5.81	5.81	4.84	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	76.88	26.85	17.18	7.17	0.50	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	105.03	22.88	25.82	11.15	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	92.19	26.02	25.45	7.64	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	138.40	23.20	42.07	9.04	1.57	0.00
Endothelial Cells - Artery, donor1	11264-116G4	123.91	34.61	28.51	8.73	0.58	0.29
Endothelial Cells - Artery, donor2	11341-117F9	116.93	27.29	32.00	9.88	1.18	0.24
Endothelial Cells - Artery, donor3	11413-118E9	97.12	31.21	27.17	7.01	0.00	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	82.68	29.26	22.83	9.31	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	80.02	24.04	20.08	5.78	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	70.48	25.94	19.45	6.20	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	93.60	35.95	23.77	14.56	0.30	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	107.78	36.97	28.64	8.33	1.04	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	55.16	32.75	23.11	10.78	0.28	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	86.03	20.41	18.41	9.20	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	111.64	25.68	45.07	8.91	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	96.66	33.42	33.92	8.45	0.25	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	69.74	25.85	21.73	9.13	0.43	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	70.47	22.11	21.25	7.57	0.24	0.00
Endothelial Cells - Vein, donor1	11267-116G7	111.48	25.03	39.81	3.41	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	137.60	30.04	31.43	6.99	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	128.12	42.71	44.43	13.03	0.63	0.16
Eosinophils, donor1	12244-129H3	45.74	60.99	15.25	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	6.60	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	0.00	7.13	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	161.26	30.05	24.68	8.06	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	126.89	14.56	14.56	4.16	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	178.96	48.81	32.54	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	37.36	21.35	9.85	3.28	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	123.06	21.68	22.34	6.90	5.26	1.20
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	77.35	24.70	21.34	9.53	1.95	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	78.35	26.68	24.62	7.88	1.46	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	114.23	22.11	20.33	7.92	0.00	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	75.94	23.94	21.83	7.59	0.74	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	34.78	8.17	5.53	4.74	0.53	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	64.78	17.61	14.95	6.64	1.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	107.51	37.20	35.38	10.43	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	84.89	21.22	18.95	4.55	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	100.62	35.96	31.54	9.31	0.95	0.16
Fibroblast - Cardiac, donor4	11452-119A3	71.53	25.46	19.70	6.37	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	60.66	18.91	17.39	6.60	0.13	0.00
Fibroblast - Cardiac, donor6	11460-119B2	66.55	23.50	18.19	7.58	0.00	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	96.47	17.95	19.29	8.04	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	47.89	21.14	13.81	5.18	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	101.07	36.62	23.44	11.72	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	124.31	44.28	26.52	10.84	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	83.78	31.72	23.91	9.16	0.34	0.17
Fibroblast - Dermal, donor1	11269-116G9	86.16	26.06	21.83	5.40	1.41	0.00
Fibroblast - Dermal, donor2	11346-117G5	91.03	24.53	25.47	4.72	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	74.83	34.45	29.13	8.22	0.48	0.24
Fibroblast - Dermal, donor4	11450-119A1	60.93	21.37	13.57	12.10	0.34	0.00
Fibroblast - Dermal, donor5	11454-119A5	56.52	19.71	15.53	9.07	0.17	0.00
Fibroblast - Dermal, donor6	11458-119A9	76.34	19.98	17.22	9.10	0.32	0.16
Fibroblast - Gingival, donor1	11237-116D4	95.37	24.57	21.03	6.66	0.00	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	84.36	22.01	25.15	7.34	1.05	0.00
Fibroblast - Gingival, donor2	11318-117D4	106.48	32.81	33.87	10.15	0.13	0.79
Fibroblast - Gingival, donor3	11394-118C8	79.38	26.59	23.11	7.25	0.19	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	60.26	17.66	17.66	5.19	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	50.57	16.39	18.33	5.46	0.35	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	84.81	22.45	19.49	7.33	0.31	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	89.52	17.44	18.66	4.46	0.68	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	82.93	21.53	22.23	7.76	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	67.13	18.13	18.13	5.56	0.29	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	103.36	18.13	21.41	6.68	0.41	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	59.23	12.51	15.14	3.62	0.11	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	71.02	22.16	20.25	6.90	0.59	0.29
Fibroblast - Lung, donor1	11270-116H1	135.93	36.70	38.06	9.52	2.72	0.00
Fibroblast - Lung, donor2	11347-117G6	80.58	29.84	32.83	5.97	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	139.71	55.08	49.17	17.52	0.63	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	142.45	24.99	34.99	7.50	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	67.13	18.18	6.99	13.99	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	78.65	32.47	24.63	10.08	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	84.04	39.38	24.76	6.90	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	59.91	27.96	19.97	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	29.78	35.74	5.96	17.87	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	93.69	42.67	28.90	7.95	0.19	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	72.66	26.39	24.27	11.07	0.15	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	53.24	18.67	12.85	4.59	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	46.94	16.41	11.83	5.72	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	59.40	19.17	24.57	9.45	0.27	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	40.59	18.21	16.47	5.57	0.23	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	89.42	32.05	28.41	6.74	0.11	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	126.99	37.59	35.36	7.11	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	80.85	39.42	30.07	5.35	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	80.65	36.37	24.91	6.33	0.79	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	38.70	10.91	8.14	6.75	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	37.12	21.14	12.08	3.91	0.00	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	55.58	30.94	19.51	8.08	0.39	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	39.41	12.64	6.32	8.12	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	67.36	22.89	18.57	7.66	0.00	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	62.76	19.23	17.21	8.60	0.00	0.51
Fibroblast - skin normal, donor1	11553-120C5	77.28	29.86	19.85	7.22	0.33	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	36.69	12.83	8.42	4.61	0.00	0.00
Fibroblast - skin normal, donor2	11561-120D4	58.17	18.69	17.18	7.33	0.10	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	69.21	18.44	10.88	11.79	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	47.97	22.62	19.47	6.79	0.17	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	80.35	19.15	19.15	6.50	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	37.44	11.82	6.24	6.24	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	76.06	26.84	16.19	8.52	0.21	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	92.77	32.72	24.46	6.24	0.00	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	86.88	31.05	33.09	8.15	0.78	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	44.32	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	131.60	2.61	16.56	0.87	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	119.96	18.55	20.28	3.99	1.04	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	109.82	19.00	17.18	5.20	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	104.50	12.78	16.61	3.32	1.02	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	200.57	66.60	51.29	25.26	4.59	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	232.26	69.55	79.12	29.35	2.55	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	251.89	85.86	68.46	23.68	2.85	1.43
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	208.20	126.85	118.58	40.26	6.62	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	179.46	68.73	79.00	27.40	7.31	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	193.57	76.87	60.43	25.96	2.97	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	179.48	125.56	122.92	39.91	4.76	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	166.66	80.88	78.60	26.74	7.50	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	211.83	69.43	56.16	24.76	1.77	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	196.30	112.78	51.87	32.79	1.41	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	196.17	82.14	47.16	22.90	0.99	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	170.85	73.07	54.80	23.10	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	171.84	70.12	41.88	22.67	0.99	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	158.91	82.92	50.25	25.06	0.55	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	130.52	52.05	39.85	16.47	1.22	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	176.15	58.41	51.57	20.76	2.74	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	153.84	57.42	44.22	22.05	0.37	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	124.15	44.59	38.91	13.11	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	210.68	73.87	63.23	31.62	2.36	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	208.87	76.62	63.27	22.89	0.64	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	167.12	60.32	45.13	20.78	0.67	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	179.25	60.89	69.36	22.38	1.21	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	260.23	76.00	61.41	23.24	0.68	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	219.55	56.57	57.73	18.00	3.19	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	217.89	88.66	79.50	31.11	0.94	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	223.55	76.00	82.48	25.79	1.37	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	172.40	75.80	56.65	27.88	0.89	0.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	196.09	59.57	61.81	19.05	1.41	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	202.34	50.43	52.88	17.56	1.02	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	163.39	78.81	78.19	29.09	1.65	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	173.17	89.35	62.37	28.13	1.04	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	149.42	56.20	51.86	18.18	0.67	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	139.31	74.73	62.82	23.37	2.42	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	171.08	89.66	61.99	29.03	1.23	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	167.44	56.57	59.97	20.59	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	144.96	79.22	73.44	25.98	3.53	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	169.23	70.97	54.86	22.36	0.95	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	128.12	47.14	50.46	15.82	1.27	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	144.14	49.57	56.26	21.89	1.22	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	168.10	57.71	50.70	19.24	1.15	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	125.15	49.62	49.40	20.20	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	170.01	58.92	54.15	17.67	1.68	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	133.51	40.74	30.83	15.65	0.65	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	124.34	36.90	40.11	13.37	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	102.21	34.12	31.83	12.85	1.22	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	131.61	43.78	31.61	15.41	0.78	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	135.27	43.64	37.68	17.35	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	116.14	43.88	47.19	14.38	1.11	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	108.56	38.82	45.40	16.45	0.88	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	124.96	45.62	47.60	11.90	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	105.79	36.28	36.54	12.53	0.66	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	100.07	35.31	38.33	13.11	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	172.32	60.24	61.00	22.37	0.51	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	144.32	85.20	36.03	27.27	1.39	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	126.96	103.85	43.30	26.50	0.31	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	163.67	133.80	48.49	35.80	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	298.85	103.58	80.11	30.04	1.25	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	305.16	126.87	75.16	31.65	2.54	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	160.04	60.88	46.12	25.83	1.38	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	222.73	81.67	42.07	14.85	4.95	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	285.85	80.07	62.28	24.37	3.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	240.67	56.16	56.16	30.48	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	238.22	93.90	78.25	24.34	3.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	241.18	65.75	54.68	15.62	4.56	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	245.85	63.83	56.01	22.24	2.88	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	193.27	73.31	73.31	16.66	10.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	241.06	67.67	57.89	22.65	4.19	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	242.84	62.43	47.39	19.28	2.94	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	176.16	82.21	60.40	15.10	1.68	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	279.59	76.34	62.02	23.54	4.45	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	261.20	69.63	58.08	22.08	2.38	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	246.40	87.70	73.09	25.06	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	296.09	91.06	96.79	33.79	5.73	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	237.67	76.96	65.12	26.05	1.78	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	235.49	71.15	60.99	11.86	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	362.43	70.42	82.43	24.02	4.56	2.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	339.21	88.14	90.67	24.16	3.91	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	242.35	36.88	68.49	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	265.24	75.34	59.97	19.22	2.69	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	231.44	58.02	59.00	16.62	4.56	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	202.66	63.54	56.18	18.73	2.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	199.18	81.68	93.23	28.12	4.24	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	197.53	60.59	63.68	22.25	2.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	124.24	86.97	39.76	12.42	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	147.22	73.14	71.72	24.06	4.72	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	160.53	72.42	73.63	21.12	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	202.96	76.81	76.30	18.31	3.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	207.40	85.35	86.15	22.33	5.58	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	178.59	85.35	71.04	15.79	1.97	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	159.36	77.91	70.83	27.15	2.36	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	194.87	79.35	82.27	30.34	3.50	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	150.98	74.17	62.76	21.51	3.51	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	144.96	66.12	77.99	29.67	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	254.29	79.99	71.03	25.67	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	295.03	67.93	79.10	17.47	4.37	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	66.20	22.83	17.12	6.85	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	56.14	19.96	19.96	7.48	0.83	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	75.34	19.12	29.24	9.00	1.12	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	61.53	18.08	18.40	5.39	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	119.47	23.39	25.90	5.85	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	373.07	42.24	57.09	15.55	1.39	0.81
Hep-2 cells mock treated, biol_rep2	11899-125E9	362.75	40.17	50.64	12.49	0.68	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	342.16	37.08	48.00	9.78	0.46	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	379.63	40.99	52.69	15.52	1.20	0.77
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	365.14	38.04	49.21	13.11	0.86	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	317.33	32.94	42.84	9.90	1.08	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	397.77	46.08	55.42	16.07	2.24	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	320.11	32.59	51.12	10.29	2.23	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	344.72	35.88	50.30	10.57	2.56	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	100.17	26.30	19.59	13.43	1.12	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	89.59	41.98	42.85	12.55	0.87	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	81.96	15.86	44.94	18.51	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	95.59	43.74	28.92	11.99	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	95.90	50.13	39.96	10.90	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	80.08	31.47	23.43	6.29	0.35	0.17
Hepatocyte, donor1	11523-119I2	134.38	30.27	14.53	4.84	0.00	0.00
Hepatocyte, donor2	11603-120I1	244.56	19.39	26.93	3.23	1.08	1.08
Hepatocyte, donor3	11684-122I1	124.55	20.86	16.57	3.68	1.23	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	454.92	43.08	93.33	20.89	0.65	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	198.03	21.85	28.31	5.07	0.17	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	89.32	29.91	20.44	9.47	0.27	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	257.90	63.68	44.57	15.92	0.00	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	146.86	106.80	60.08	20.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	270.83	81.25	54.17	81.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	179.97	60.91	58.14	9.69	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	202.72	95.10	62.57	15.02	2.50	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	415.39	71.21	83.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	210.16	64.07	69.20	10.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	150.84	86.84	54.85	13.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	237.15	77.97	69.85	22.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	223.42	88.37	51.69	20.01	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	188.79	72.61	39.94	18.15	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	227.64	78.08	63.53	22.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	200.66	60.98	59.87	12.20	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	183.34	89.05	52.38	20.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	228.64	63.62	48.50	23.93	0.63	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	230.45	61.86	54.13	23.20	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	131.71	14.63	43.90	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	241.62	83.98	64.60	30.36	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	218.95	66.01	70.84	12.88	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	143.38	59.74	47.79	23.90	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	233.87	72.52	53.78	21.19	1.63	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	265.74	88.58	80.60	20.57	0.84	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	114.98	14.37	57.49	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	233.87	95.64	54.65	25.72	0.80	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	173.58	63.71	43.39	7.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	90.48	75.40	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	211.94	77.41	53.34	20.30	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	202.26	57.14	52.60	20.86	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	176.91	58.97	58.97	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	223.83	64.57	44.12	11.84	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	237.58	68.61	62.25	20.33	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	213.59	49.29	98.58	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	219.36	68.87	49.10	18.49	0.00	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	238.77	52.86	65.62	16.40	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	126.43	31.61	31.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	202.79	54.27	54.98	22.14	0.71	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	245.56	59.73	43.14	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	104.24	20.85	41.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	206.80	65.44	50.93	20.99	0.93	1.23
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	228.28	56.19	24.58	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	194.87	72.29	50.29	18.86	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	207.23	73.71	44.50	29.90	0.70	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	232.37	88.52	64.18	24.34	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	246.39	94.02	55.11	12.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	217.98	88.07	60.16	25.29	0.87	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	245.23	89.99	67.49	20.25	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	250.89	76.66	66.21	24.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	293.36	97.08	42.67	38.40	2.13	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	239.68	48.49	47.11	19.40	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	233.67	76.94	51.29	8.55	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	258.64	82.84	54.31	32.21	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	196.65	96.81	72.61	36.30	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	217.30	62.09	37.25	12.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	218.88	108.91	70.84	24.32	1.06	2.11
Keratinocyte - epidermal, donor1	11272-116H3	114.73	19.75	21.95	7.26	0.41	0.00
Keratinocyte - epidermal, donor2	11349-117G8	100.73	18.74	20.50	7.03	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	83.01	21.01	20.26	5.68	0.19	0.28
Keratinocyte - oral, donor1	11251-116E9	134.06	49.83	49.38	10.78	0.45	0.11
Keratocytes, donor1	11527-119I6	94.90	34.04	25.10	6.53	0.00	0.00
Keratocytes, donor2	11607-120I5	70.31	19.92	24.61	4.69	0.00	0.00
Keratocytes, donor3	11688-122I5	49.79	20.15	16.99	6.13	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	24.18	2.20	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	131.61	35.60	35.60	12.94	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	216.71	73.47	49.94	18.80	0.35	0.35
Lens Epithelial Cells, donor3	11690-122I7	93.04	38.14	26.84	7.47	0.20	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	83.24	30.95	29.41	9.72	0.36	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	73.40	33.77	22.33	13.67	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	82.01	34.63	21.57	12.59	0.94	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	67.75	25.27	18.28	10.75	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	66.82	29.31	23.01	11.66	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	90.56	35.58	27.82	11.64	0.54	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	59.10	22.57	19.70	10.67	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	97.84	37.67	26.55	16.94	0.51	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	81.35	30.40	22.66	11.96	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	59.73	24.13	19.38	9.10	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	83.76	29.08	27.73	12.80	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	95.91	38.88	29.25	13.52	0.56	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	56.10	30.31	25.43	8.71	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	76.80	37.45	22.90	13.60	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	85.02	31.86	26.23	14.28	0.41	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	59.13	30.18	17.86	7.70	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	87.60	35.85	31.17	16.52	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	99.55	39.16	29.46	15.19	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	65.49	25.34	16.78	7.90	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	92.55	33.97	32.22	15.82	0.29	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	115.01	37.84	32.86	16.93	1.00	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	53.83	22.79	23.28	9.70	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	80.79	28.81	24.51	15.08	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	97.18	33.91	24.52	12.56	0.45	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	78.80	23.85	23.33	10.37	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	81.24	26.59	21.57	12.14	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	91.43	32.48	26.16	11.58	0.60	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	70.85	33.71	17.20	10.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	82.79	35.75	25.78	14.68	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	89.38	37.00	30.64	14.31	0.85	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	55.73	26.17	19.87	5.81	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	81.70	27.79	34.73	13.89	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	92.92	33.95	25.15	11.40	0.99	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	73.67	22.95	21.84	9.63	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	77.83	32.12	25.70	11.61	0.99	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	93.77	30.39	27.22	13.47	0.55	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	55.00	31.84	20.58	7.40	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	78.52	29.82	24.04	13.69	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	77.82	33.73	26.87	12.60	0.42	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	67.20	26.31	19.20	9.96	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	91.62	28.12	27.15	13.57	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	104.72	38.75	33.77	16.81	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	69.47	24.71	20.77	10.74	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	84.94	29.73	23.85	8.82	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	115.83	38.14	28.72	15.30	0.71	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	78.95	26.73	23.88	7.05	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	91.69	34.06	27.92	12.04	1.02	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	80.56	25.36	21.48	10.14	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	169.95	24.93	33.99	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	192.55	32.22	23.78	7.67	1.53	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	169.23	24.49	19.30	7.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	233.14	27.50	35.97	7.19	1.69	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	165.98	23.21	27.43	8.44	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	174.65	26.15	27.09	6.54	2.80	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	185.50	21.13	29.37	8.24	0.52	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	176.04	27.36	23.79	4.76	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	246.55	30.31	38.45	9.73	0.90	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	173.33	19.19	27.05	7.27	0.58	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	183.67	22.51	27.91	7.65	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	238.46	28.99	38.34	8.40	0.41	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	196.17	21.57	30.30	10.78	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	170.43	21.52	21.17	6.00	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	144.59	21.99	27.98	3.33	2.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	183.38	27.00	30.05	6.62	1.02	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	176.09	24.28	27.48	6.40	0.80	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	184.60	23.05	24.00	7.56	1.13	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	205.54	21.47	29.45	4.29	0.61	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	199.78	27.72	26.09	5.71	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	161.39	27.49	21.24	8.33	0.42	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	177.41	19.62	26.34	6.73	1.12	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	179.28	22.67	28.85	7.21	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	188.99	23.80	25.55	6.97	0.87	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	178.76	18.23	27.50	5.98	0.90	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	153.81	21.58	20.47	4.98	1.11	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	196.89	26.87	26.16	7.78	1.41	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	180.70	19.55	27.29	3.32	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	227.95	17.27	29.93	9.21	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	201.09	24.94	23.79	5.76	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	189.65	21.51	31.14	5.66	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	193.63	24.61	27.90	9.85	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	208.77	25.76	32.54	10.39	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	221.91	22.26	31.60	8.62	1.44	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	189.71	31.37	29.13	7.47	0.75	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	219.98	21.18	27.87	7.06	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	179.19	16.37	30.15	6.03	0.00	1.72
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	189.24	29.97	25.69	7.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	215.90	24.66	29.32	10.99	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	182.80	22.93	28.96	9.65	2.41	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	207.61	31.28	31.28	7.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	177.36	26.47	29.90	9.62	0.34	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	195.91	19.86	33.28	8.59	0.00	2.15
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	199.99	28.28	30.97	9.43	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	196.69	20.00	28.15	6.67	0.00	1.48
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	184.91	25.58	40.70	9.30	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	189.34	21.15	34.91	5.29	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	201.68	24.41	28.01	11.20	0.40	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	201.34	19.63	28.35	3.63	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	238.39	30.66	32.19	9.20	0.00	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	218.52	33.54	43.90	8.88	1.97	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	190.07	8.47	33.87	7.53	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	225.26	26.15	29.16	7.54	0.50	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	205.94	21.63	27.04	6.31	1.35	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	196.21	15.49	36.14	6.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	225.79	28.06	31.17	11.58	0.00	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	191.21	27.76	28.15	6.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	192.64	17.15	23.75	6.60	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	212.76	28.54	30.10	6.23	1.04	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	182.90	20.57	31.50	7.88	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	194.01	17.33	28.51	8.39	0.56	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	198.74	23.41	35.77	6.62	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	184.37	26.61	32.01	8.87	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	185.33	16.20	29.37	8.10	1.01	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	181.19	21.15	28.84	2.88	0.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	193.21	20.67	26.64	7.16	1.99	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	153.12	19.44	25.52	6.08	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	153.56	20.75	15.91	6.23	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	183.92	19.76	24.70	6.46	1.52	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	186.94	15.49	23.76	5.68	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	168.70	19.95	19.95	5.44	0.60	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	189.51	24.40	34.54	7.61	1.27	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	161.53	14.39	25.06	5.33	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	187.34	17.24	21.26	8.62	1.15	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	194.89	15.94	32.40	7.20	2.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	197.35	21.22	27.59	9.90	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	192.38	14.19	21.00	5.11	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	199.28	24.55	30.37	9.57	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	202.02	12.53	32.10	7.83	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	212.53	18.79	19.21	9.60	0.84	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	191.43	28.34	27.41	5.58	0.00	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	224.13	14.72	36.13	10.70	1.34	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	203.70	22.99	20.32	4.81	0.53	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	224.27	23.84	29.09	3.64	1.21	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	180.80	23.86	33.04	9.18	1.84	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	208.94	20.45	17.78	8.89	1.78	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	205.15	29.06	31.91	7.41	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	210.90	19.94	26.84	12.27	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	200.81	27.36	16.96	12.04	1.09	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	183.97	26.28	24.50	6.24	0.45	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	257.62	32.23	29.89	6.24	0.52	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	231.42	28.51	25.20	9.28	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	255.67	18.71	51.97	10.39	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	5.93	4.33	5.47	0.68	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	14.86	8.44	3.30	1.84	0.37	0.00
Macrophage - monocyte derived, donor3	11389-118C3	17.56	6.95	4.98	1.70	0.13	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	204.97	21.24	24.43	9.56	1.59	0.00
Mallassez-derived cells, donor2	11929-125I3	107.91	20.28	25.83	2.85	0.16	0.00
Mallassez-derived cells, donor3	11930-125I4	154.55	16.68	25.16	4.45	0.00	0.14
Mammary Epithelial Cell, donor1	11273-116H4	75.43	22.02	15.05	3.89	0.00	0.10
Mammary Epithelial Cell, donor2	11350-117G9	110.61	20.85	22.30	4.92	0.58	0.00
Mammary Epithelial Cell, donor3	11422-118F9	132.20	26.44	26.44	6.73	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	30.51	36.61	23.73	11.52	0.00	0.00
Mast cell, donor1	11563-120D6	43.58	35.58	16.55	8.33	1.51	0.00
Mast cell, donor2	11565-120D8	20.80	27.34	22.59	8.92	1.49	0.59
Mast cell, donor3	11566-120D9	27.69	30.17	21.39	9.68	1.35	0.00
Mast cell, donor4	11567-120E1	24.11	36.34	21.63	7.98	1.60	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	19.18	25.17	12.20	7.76	0.00	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	30.35	22.18	16.34	7.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	28.57	24.32	16.63	11.36	0.80	0.23
Mast cell, expanded, donor8	11941-126A6	42.01	27.45	14.39	11.38	2.01	0.00
Melanocyte - dark, donor1	11502-119F8	102.78	43.18	27.56	14.33	0.20	0.10
Melanocyte - dark, donor2	11582-120F7	105.56	34.95	24.92	10.04	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	104.97	31.87	24.85	8.84	0.07	0.07
Melanocyte - light, donor1	11274-116H5	130.23	35.26	34.79	8.70	1.88	0.00
Melanocyte - light, donor2	11351-117H1	182.22	42.31	48.46	10.92	5.46	0.00
Melanocyte - light, donor3	11423-118G1	91.06	26.02	20.81	10.41	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	97.67	33.42	26.55	8.85	0.10	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	104.89	23.40	28.78	7.80	0.81	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	103.66	25.71	32.14	8.84	0.80	0.27
Meningeal Cells, donor1	11493-119E8	74.81	20.47	19.35	7.69	0.00	0.00
Meningeal Cells, donor2	11573-120E7	79.67	26.41	16.73	13.20	0.00	0.00
Meningeal Cells, donor3	11654-122E7	57.38	22.66	18.83	6.68	0.00	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	134.88	54.18	41.63	10.55	0.86	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	87.65	22.74	21.84	6.14	0.30	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	102.50	61.77	35.48	14.46	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	103.34	34.01	23.55	10.47	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	44.49	19.38	15.07	5.02	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	83.22	25.84	24.99	6.35	0.64	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	91.98	25.13	33.17	4.02	2.01	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	142.62	41.31	31.86	9.45	0.00	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	113.97	29.22	27.03	7.31	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	135.45	34.99	33.96	10.43	0.00	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	157.21	21.33	32.00	7.89	0.42	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	142.74	52.78	40.52	15.61	0.74	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	84.60	39.34	36.31	6.45	0.26	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	77.75	31.16	22.26	5.64	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	88.75	39.70	37.37	7.01	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	153.06	49.95	42.27	18.57	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	57.77	41.47	18.43	9.92	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	95.38	51.91	40.03	9.69	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	111.76	49.35	34.83	5.81	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	126.22	28.37	26.25	9.55	0.27	0.80
Mesothelial Cells, donor2	12156-128G5	170.66	31.53	37.03	10.01	1.50	0.50
Mesothelial Cells, donor3	11402-118D7	77.03	20.09	18.72	5.13	0.29	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	5.40	1.35	0.00	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	19.21	9.11	3.20	2.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	30.62	15.90	7.66	3.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	18.29	6.51	2.79	0.31	0.31	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	24.68	9.54	6.02	2.90	0.00	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	0.00	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	18.27	8.26	6.26	2.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	27.00	7.91	5.12	3.72	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	17.68	5.49	4.88	2.44	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	23.76	17.03	6.34	3.56	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	11.50	4.42	4.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	31.91	12.16	9.12	4.94	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	2.63	0.00	0.00	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	14.43	8.28	4.88	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	13.81	1.84	3.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	11.03	5.07	1.49	1.79	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	8.38	0.00	6.71	0.00	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	15.56	6.02	5.52	2.51	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	21.63	9.51	4.99	2.85	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	0.00	0.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	14.28	5.07	2.53	1.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	23.35	9.89	6.52	2.94	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	2.24	2.85	1.22	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	13.73	4.29	4.51	1.07	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	14.00	5.11	3.33	2.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	9.64	4.82	3.50	2.19	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	12.67	4.56	5.58	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	0.00	1.66	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	7.07	2.45	3.53	1.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	21.47	5.88	5.59	4.12	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	0.00	2.18	0.00	2.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	10.57	4.32	2.88	0.48	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	24.41	9.61	6.40	2.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	0.00	0.00	1.37	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	12.51	2.50	8.51	1.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	26.95	26.95	26.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	8.76	4.82	3.50	2.19	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	9.93	4.41	3.31	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	0.64	1.28	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	15.12	4.96	3.22	1.49	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	6.26	4.87	1.39	2.78	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	15.38	5.81	4.10	0.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	7.44	2.19	2.19	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	1.78	0.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	15.43	6.17	1.96	1.68	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	10.39	2.49	0.83	1.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	2.33	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	6.94	3.32	1.81	1.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	16.28	7.51	3.34	1.67	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	2.77	2.77	0.92	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	13.09	3.41	0.57	2.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	1.66	0.83	0.69	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	8.29	4.92	3.89	1.04	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	11.58	2.57	2.14	1.72	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	3.81	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	5.07	1.87	2.94	1.33	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	12.27	5.09	4.19	0.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	2.26	0.99	0.57	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	11.47	3.50	1.91	0.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	14.82	4.64	1.77	1.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	2.28	0.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	10.51	4.26	1.99	0.28	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	13.52	3.69	2.46	2.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	1.30	0.65	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	7.35	1.76	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	14.42	8.94	3.17	2.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	1.65	2.89	0.82	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	5.36	1.79	3.87	0.30	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	7.53	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	7.13	8.91	5.35	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	9.20	4.60	1.97	1.64	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	7.36	10.52	8.42	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	6.13	2.57	5.14	0.99	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	9.31	4.66	2.79	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	4.88	5.26	2.63	0.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	11.99	6.39	3.20	1.07	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	7.24	2.26	2.38	1.13	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	10.31	4.42	1.47	1.47	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	6.96	3.30	3.66	1.83	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	9.33	4.67	3.11	3.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	7.48	4.28	2.14	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	3.86	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	8.08	5.05	2.02	1.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	10.96	4.22	4.64	1.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	6.81	2.72	2.72	2.72	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	26.07	6.36	6.99	1.91	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	19.44	8.91	8.91	4.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	6.04	1.51	3.02	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	0.00	5.71	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	29.36	6.52	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	23.76	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	63.12	21.11	17.02	3.02	0.22	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	38.15	22.47	10.45	6.27	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	66.75	13.35	22.03	12.68	1.33	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	60.94	17.11	12.94	5.84	0.42	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	72.63	23.01	32.89	4.94	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	49.47	20.75	17.55	9.58	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	55.76	12.92	13.60	3.40	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	42.27	16.54	14.70	0.00	3.68	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	59.85	15.90	18.42	9.21	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	94.37	19.99	24.17	8.83	0.46	0.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	71.61	17.29	17.02	8.92	0.81	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	57.39	15.98	13.03	5.26	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	89.08	0.00	22.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	100.76	13.90	27.80	12.41	1.49	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	64.15	15.70	22.19	5.14	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	84.33	19.72	22.21	5.44	0.68	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	56.50	14.70	16.17	4.90	0.33	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	53.04	14.40	16.22	6.74	0.18	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	80.10	18.03	21.75	9.55	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	60.63	13.81	13.21	7.80	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	77.78	18.05	24.29	3.61	0.98	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	55.13	13.01	17.24	5.69	0.00	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	37.39	12.88	12.35	6.88	0.35	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	73.14	18.99	15.47	4.22	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	64.36	14.25	15.63	3.68	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	71.02	15.75	18.00	4.82	0.64	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	65.53	11.04	28.28	1.38	0.34	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	32.87	25.28	10.11	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	36.54	9.36	10.92	4.68	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	52.08	11.01	11.01	5.08	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	55.07	11.87	12.82	4.75	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	58.81	22.32	13.74	7.30	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	9.03	27.08	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	62.98	13.33	17.66	4.67	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	23.44	8.57	3.16	4.06	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	44.04	7.14	12.30	5.16	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	48.29	5.57	24.14	5.57	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	57.13	20.43	18.54	4.16	0.38	1.89
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	51.49	12.06	10.10	6.52	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	31.38	10.89	14.38	3.92	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	34.37	8.59	8.14	3.62	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	47.62	18.52	11.46	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	45.21	9.31	10.64	7.31	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	67.96	16.87	19.84	10.91	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	32.16	8.42	11.10	3.83	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	68.66	21.47	22.99	4.54	0.60	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	34.70	11.71	10.61	3.32	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	51.50	12.20	14.23	4.74	0.68	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	30.66	5.11	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	54.26	20.73	18.29	6.71	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	32.42	11.02	13.22	6.29	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	45.10	13.62	16.04	3.33	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	48.26	15.82	15.82	6.33	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	45.35	6.80	12.47	1.13	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	30.35	20.23	15.17	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	82.74	19.26	19.26	5.34	0.12	0.12
Myoblast, donor2	11322-117D8	99.54	22.06	24.55	4.22	0.58	0.38
Myoblast, donor3	11398-118D3	79.54	21.19	17.15	5.72	0.34	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	34.44	11.69	16.30	4.00	0.31	0.00
Natural Killer Cells, donor2	11311-117C6	39.81	11.16	14.47	3.62	0.30	0.30
Natural Killer Cells, donor3	11387-118C1	31.47	12.70	15.09	2.02	0.00	0.00
Neural stem cells, donor1	11275-116H6	174.21	42.10	51.17	13.07	2.18	0.00
Neural stem cells, donor2	11352-117H2	163.68	63.55	59.69	23.11	0.00	0.00
Neurons, donor1	11494-119E9	267.41	95.58	103.55	23.90	1.14	1.14
Neurons, donor2	11574-120E8	270.36	115.59	117.79	30.60	0.44	0.00
Neurons, donor3	11655-122E8	256.52	84.68	93.73	25.49	0.00	4.93
Neutrophils, donor1	11233-116C9	0.93	0.00	0.93	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	2.44	0.00	1.22	0.61	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	103.30	37.88	30.16	7.96	0.36	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	139.36	32.23	37.44	8.47	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	114.31	21.26	21.26	7.02	0.40	0.20
Olfactory epithelial cells, donor1	11933-125I7	38.68	15.42	13.77	4.82	0.14	0.14
Olfactory epithelial cells, donor2	11934-125I8	52.69	16.07	18.09	5.36	0.29	0.00
Olfactory epithelial cells, donor3	11935-125I9	35.30	13.85	13.73	4.31	0.23	0.23
Olfactory epithelial cells, donor4	11936-126A1	38.96	17.63	13.73	6.53	0.19	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	109.53	37.31	33.10	6.62	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	95.71	25.74	22.76	7.66	2.55	0.00
Osteoblast - differentiated, donor2	11353-117H3	92.59	32.01	36.58	3.43	13.72	0.00
Osteoblast - differentiated, donor3	11425-118G3	45.31	25.45	22.35	4.97	0.62	0.00
Osteoblast, donor1	11277-116H8	207.36	83.65	59.02	21.30	0.78	0.00
Osteoblast, donor2	11354-117H4	77.96	33.71	21.77	7.73	0.70	0.00
Osteoblast, donor3	11426-118G4	149.65	46.57	43.19	9.95	0.36	0.53
Pancreatic stromal cells, donor1	11249-116E7	72.78	21.31	20.05	5.98	0.25	0.00
Pericytes, donor1	11491-119E6	158.33	45.62	39.28	16.36	0.33	0.00
Pericytes, donor2	11571-120E5	86.70	28.97	20.83	11.77	0.23	0.23
Pericytes, donor3	11652-122E5	122.07	51.88	35.40	8.34	0.00	0.00
Perineurial Cells, donor1	11499-119F5	60.69	31.19	17.52	7.12	0.00	0.00
Perineurial Cells, donor2	11579-120F4	104.52	41.59	28.16	9.57	0.28	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	35.70	12.43	13.71	1.91	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	26.69	6.61	10.77	1.71	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	27.95	6.60	11.78	1.81	0.00	0.00
Placental Epithelial Cells, donor1	11278-116H9	93.27	40.42	25.83	9.81	1.43	0.00
Placental Epithelial Cells, donor2	11355-117H5	124.20	62.10	42.14	15.52	2.22	0.00
Placental Epithelial Cells, donor3	11427-118G5	103.86	46.92	32.00	14.72	0.20	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	57.59	26.58	22.47	9.81	1.27	0.95
Preadipocyte - breast, donor1	11467-119B9	81.60	23.26	22.70	7.88	0.56	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	47.51	25.58	13.71	7.18	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	45.25	22.06	21.16	10.13	0.45	0.00
Preadipocyte - omental, donor1	11468-119C1	67.66	22.38	23.98	8.74	0.75	0.11
Preadipocyte - omental, donor2	11329-117E6	84.68	23.57	31.43	6.98	2.18	0.00
Preadipocyte - omental, donor3	11403-118D8	61.17	22.49	15.33	8.31	1.29	0.00
Preadipocyte - perirenal, donor1	11469-119C2	116.14	27.56	24.61	4.92	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	117.01	30.10	24.88	10.44	0.31	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	67.11	21.07	20.01	7.08	0.18	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	62.84	33.55	24.01	8.17	1.19	0.17
Preadipocyte - visceral, donor1	11280-116I2	74.52	22.73	17.51	7.17	0.28	0.00
Preadipocyte - visceral, donor2	11357-117H7	95.72	22.55	27.61	6.44	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	62.07	17.45	14.42	7.73	0.10	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	210.14	21.42	27.76	7.09	3.92	0.15
Prostate Epithelial Cells, donor2	11331-117E8	164.12	20.85	22.75	5.69	1.76	0.41
Prostate Epithelial Cells, donor3	11404-118D9	26.03	6.80	5.63	0.80	0.49	0.12
Prostate Stromal Cells, donor1	11254-116F3	117.55	27.79	26.99	7.18	0.46	0.11
Prostate Stromal Cells, donor2	11332-117E9	71.00	16.67	20.80	6.10	0.00	0.18
Prostate Stromal Cells, donor3	11405-118E1	84.78	26.69	23.15	6.88	2.09	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	152.56	58.76	42.34	10.95	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	89.00	36.53	38.75	10.74	0.21	0.14
Renal Epithelial Cells, donor1	11517-119H5	252.09	77.61	61.37	26.88	1.01	0.00
Renal Epithelial Cells, donor2	11597-120H4	187.08	46.24	43.39	17.78	1.42	0.00
Renal Epithelial Cells, donor3	11678-122H4	105.44	39.81	40.86	12.70	0.64	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	87.83	28.60	21.11	8.17	1.36	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	93.93	24.93	20.08	11.05	0.40	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	58.39	20.20	21.98	5.11	0.00	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	131.76	49.91	39.93	15.31	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	178.05	48.86	43.80	12.99	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	122.89	53.92	49.53	19.44	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	157.57	54.10	52.71	18.03	0.55	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	154.07	46.44	31.94	11.81	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	112.59	30.36	33.31	7.59	0.42	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	171.44	52.07	48.40	15.81	0.39	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	199.13	55.23	42.78	19.71	0.26	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	171.97	52.30	37.24	18.48	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	217.15	47.34	46.31	8.23	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	122.44	23.33	38.14	16.31	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	121.47	22.05	22.85	4.01	0.53	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	0.00	0.00	0.00	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	1.65	0.55	0.55	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	0.58	1.16	0.58	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	2.73	0.91	0.91	0.65	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	2.38	1.99	0.79	0.70	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	2.45	1.34	0.89	0.56	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	3.10	1.49	0.25	0.50	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	2.45	1.63	1.28	0.93	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	1.62	1.39	1.39	0.92	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	2.05	0.41	0.55	0.41	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	1.36	0.76	2.27	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	1.61	1.25	1.25	1.08	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	3.16	1.58	1.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	1.72	2.15	1.07	0.86	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	1.33	0.66	0.89	0.66	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	1.53	0.19	0.38	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	1.02	1.40	1.30	0.47	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	3.01	0.75	1.50	0.56	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	1.46	1.06	0.40	0.40	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	1.56	1.27	1.27	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	1.34	1.34	0.38	0.38	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	2.78	1.07	1.28	0.53	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	1.96	0.84	1.40	0.84	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	1.20	0.68	0.85	0.51	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	1.46	0.73	0.36	0.55	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	2.70	0.25	1.72	0.25	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	2.28	1.07	1.07	0.81	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	3.30	0.71	0.47	0.24	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	1.19	0.20	0.99	0.79	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	2.34	1.17	1.17	0.23	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	2.28	0.41	0.83	0.62	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	1.77	0.88	1.11	0.44	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	1.88	1.25	1.25	0.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	2.56	1.48	0.67	0.40	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	1.19	1.02	0.68	0.17	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	0.58	0.96	0.39	0.58	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	1.55	0.86	1.72	0.34	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	1.23	0.96	1.10	0.69	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	0.99	1.64	0.66	0.33	0.00	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	2.56	0.68	0.17	0.34	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	2.66	1.48	1.92	0.74	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	2.40	0.53	0.80	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	1.66	0.97	0.97	1.11	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	4.76	2.86	2.38	1.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	2.02	0.81	2.42	1.01	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	3.01	1.04	1.70	1.32	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	3.84	2.10	2.79	1.75	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	1.51	0.00	0.00	0.00	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	3.55	1.22	1.10	0.98	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	1.46	1.31	0.73	0.87	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	2.43	0.61	2.43	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	2.41	1.81	0.30	0.00	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	1.81	1.13	0.90	1.13	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	3.29	1.80	0.90	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	1.89	0.83	0.71	0.94	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	2.13	1.49	2.77	0.85	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	1.20	0.60	1.80	0.60	0.00	0.00
Schwann Cells, donor1	11498-119F4	119.05	44.57	31.78	16.36	0.38	0.56
Schwann Cells, donor2	11578-120F3	85.06	40.83	40.83	10.21	0.00	0.00
Schwann Cells, donor3	11659-122F3	96.18	32.86	24.54	11.83	0.22	0.22
Sebocyte, donor1	11220-116B5	122.70	36.15	27.94	4.38	0.00	0.00
Sebocyte, donor2	11301-117B5	86.86	22.06	16.08	4.14	0.92	0.46
Sebocyte, donor3	11378-118B1	80.80	25.15	22.67	5.36	0.21	0.00
Sertoli Cells, donor1	11255-116F4	140.81	36.45	48.04	9.94	4.97	0.00
Sertoli Cells, donor2	11333-117F1	177.94	22.59	19.77	11.30	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	63.61	27.71	21.11	6.86	0.70	0.00
Skeletal Muscle Cells, donor2	11358-117H8	61.44	19.52	13.73	5.06	1.45	0.00
Skeletal Muscle Cells, donor3	11430-118G8	118.72	35.95	37.62	12.54	0.00	1.67
Skeletal Muscle Cells, donor4	11451-119A2	76.35	24.66	16.34	9.90	0.31	0.16
Skeletal Muscle Cells, donor5	11455-119A6	83.69	22.15	19.62	9.96	0.59	0.30
Skeletal Muscle Cells, donor6	11459-119B1	67.26	22.47	16.78	7.70	0.46	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	108.49	48.01	40.95	15.62	0.25	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	86.18	39.95	31.39	8.56	0.00	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	87.50	35.32	23.02	10.02	0.10	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	54.85	27.04	16.01	9.60	0.25	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	119.42	41.98	36.19	15.20	2.17	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	151.08	32.61	32.61	14.31	1.24	0.83
Skin - palm, donor1	10286-104F7	37.61	0.00	5.37	5.37	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	100.04	14.99	18.31	5.91	1.01	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	58.89	12.27	8.18	3.27	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	111.52	17.01	14.67	5.71	0.39	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	95.50	15.57	17.38	3.34	0.97	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	51.06	9.99	11.82	3.66	0.14	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	67.24	15.86	9.30	3.17	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	32.00	6.60	6.07	1.20	0.07	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	157.07	30.55	25.00	14.81	1.54	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	77.37	17.12	15.34	7.78	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	153.42	36.45	34.09	11.76	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	63.42	22.10	20.55	7.29	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	168.93	36.62	34.26	8.66	1.18	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	166.87	33.99	33.99	7.73	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	107.08	24.02	32.02	7.01	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	143.72	40.99	36.20	11.31	0.67	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	83.79	23.27	27.49	5.54	0.89	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	103.32	19.59	20.74	5.25	1.15	0.51
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	71.96	32.23	21.49	4.88	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	88.30	34.26	21.85	11.22	0.30	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	56.95	26.34	19.08	6.98	0.57	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	114.20	38.39	30.58	10.09	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	37.75	15.22	12.48	3.35	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	153.56	53.80	39.91	12.63	0.76	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	104.05	24.48	18.36	12.24	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	103.47	28.61	26.70	9.54	1.43	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	70.79	27.28	24.92	6.64	0.15	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	91.91	24.75	26.26	7.32	0.65	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	97.93	29.91	26.03	8.50	0.42	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	160.40	39.13	33.57	10.52	1.24	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	182.16	18.32	33.41	4.31	2.16	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	124.62	32.28	20.62	12.85	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	131.78	43.36	36.53	14.34	0.00	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	80.49	32.43	30.78	9.97	0.24	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	199.37	30.59	38.85	8.55	5.03	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	110.59	21.16	24.35	6.14	0.68	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	178.73	25.96	35.02	13.89	0.60	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	100.14	35.50	18.81	8.74	0.26	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	106.79	21.17	16.38	8.66	0.27	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	116.58	27.92	25.29	9.52	1.63	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	58.09	21.05	18.26	6.09	1.78	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	110.52	36.94	28.95	11.61	0.30	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	84.02	24.76	29.26	5.25	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	76.24	16.80	9.05	10.34	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	181.38	56.27	54.41	16.28	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	181.76	30.80	34.33	15.15	0.50	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	159.52	19.43	26.95	5.64	0.63	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	125.67	32.15	25.96	7.08	0.59	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	77.39	28.16	15.99	6.91	0.25	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	53.26	25.69	21.49	5.61	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	163.64	39.29	39.87	10.36	0.72	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	116.77	35.44	37.73	9.18	1.27	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	116.20	33.66	29.33	12.03	0.94	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	106.90	43.74	26.13	7.83	0.28	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	80.10	38.37	24.47	11.73	0.08	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	80.00	54.76	41.43	12.86	0.95	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	154.38	40.37	41.59	12.23	0.98	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	111.80	27.40	23.64	11.05	1.10	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	89.53	37.16	26.33	5.85	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	50.34	13.61	13.99	4.47	1.17	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	47.87	14.81	15.07	4.50	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	123.49	24.55	20.83	4.84	4.09	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	74.38	12.94	21.56	5.03	0.72	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	99.36	13.63	25.83	3.97	0.28	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	77.59	18.51	17.72	3.94	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	67.55	18.03	18.54	5.59	0.76	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	48.32	12.78	15.97	5.59	1.20	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	68.55	14.21	17.56	4.18	1.25	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	50.88	20.17	17.42	4.58	0.92	0.00
Synoviocyte, donor1	11291-117A4	34.84	18.01	13.30	7.41	0.50	0.00
Synoviocyte, donor2	11368-117I9	68.22	23.80	18.61	5.20	0.67	0.84
Synoviocyte, donor3	11440-118H9	66.80	13.85	15.86	5.81	0.22	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	151.15	52.89	35.38	10.36	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	79.28	29.73	41.62	9.91	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	139.39	56.96	50.01	14.82	0.46	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	104.37	21.36	18.35	4.87	0.22	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	122.15	28.61	25.51	5.41	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	119.11	18.90	18.90	10.31	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	115.15	20.42	21.65	4.92	1.11	0.12
Urethra, donor2	10319-105A4	53.95	3.60	21.58	3.60	0.00	0.00
Urothelial Cells, donor1	11520-119H8	125.66	36.93	25.50	6.64	0.27	0.00
Urothelial Cells, donor2	11600-120H7	103.75	29.24	24.84	5.61	0.40	0.00
Urothelial Cells, donor3	11681-122H7	102.00	35.53	30.03	11.23	0.46	0.00
Urothelial cells, donor0	11216-116B1	57.51	34.33	22.51	7.58	0.45	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	213.55	14.24	24.91	3.56	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	321.66	32.88	32.88	2.86	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	122.53	14.37	27.38	4.11	0.00	2.74
Whole blood (ribopure), donor090325, donation1	12176-128I7	52.68	13.77	18.59	5.85	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	54.62	16.27	19.17	3.49	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	172.85	7.29	28.11	5.21	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	194.57	14.68	25.70	2.75	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	136.93	25.56	31.04	2.74	0.91	0.91
Wilms' tumor cell line:G-401	10809-111A8	144.95	28.74	21.71	6.66	0.49	0.12
Wilms' tumor cell line:HFWT	10597-108E3	51.04	22.88	14.96	5.28	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	131.84	28.21	30.17	11.73	0.00	0.00
achilles tendon, donor2	10292-104G4	35.13	2.07	6.20	2.07	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	171.33	46.15	37.22	13.51	0.76	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	66.63	26.70	19.50	13.93	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	17.33	4.63	5.70	1.42	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	116.46	36.74	23.95	13.88	0.27	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	198.16	50.31	55.94	12.65	0.56	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	0.00	0.63	0.00	0.21	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	70.23	20.96	18.51	6.26	0.27	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	3.08	2.64	0.88	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	0.82	2.45	2.04	0.82	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	8.93	12.81	6.60	3.49	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	3.13	3.13	1.29	1.29	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	3.90	11.70	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	83.37	48.16	39.35	13.46	0.00	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	100.82	40.62	34.78	16.37	0.29	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	70.18	14.41	22.31	7.90	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	44.83	12.34	9.87	7.81	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	108.97	15.96	15.04	9.21	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	142.52	24.75	27.31	8.96	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	151.34	38.21	30.03	10.01	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	169.22	30.81	35.87	10.59	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	181.45	22.68	19.01	9.67	1.00	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	243.42	42.74	40.88	16.72	0.00	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	647.10	40.68	64.41	9.79	1.51	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	35.61	18.74	9.37	3.75	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	278.13	22.14	28.97	3.06	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	94.62	17.84	19.08	6.67	1.55	0.16
adipose, donor1	10184-103D4	252.16	120.80	147.78	21.11	13.49	0.00
adipose, donor2	10185-103D5	109.49	83.94	68.13	30.82	6.08	0.41
adipose, donor3	10186-103D6	162.83	75.42	80.05	28.59	5.72	0.27
adipose, donor4	10187-103D7	139.55	54.61	45.94	16.47	3.47	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	144.72	33.46	23.83	19.41	0.47	0.16
adrenal gland, adult, pool1	10081-102A9	189.16	58.20	58.20	7.28	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	51.76	41.62	15.61	13.47	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	131.13	28.23	42.16	8.22	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	111.29	22.95	23.42	4.87	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	130.17	32.46	25.02	8.45	2.03	0.00
amniotic membrane cells, donor3	12237-129G5	159.38	23.27	24.45	5.60	0.59	0.29
amygdala - adult, donor10196	10167-103B5	164.83	45.06	49.80	16.60	0.00	1.19
amygdala, adult, donor10252	10151-102I7	116.59	44.00	49.07	8.52	0.41	0.20
amygdala, newborn, donor10223	10360-105E9	118.78	37.76	33.89	16.78	0.65	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	90.15	23.81	25.98	7.64	0.76	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	332.04	39.93	45.45	12.35	1.10	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	183.39	96.87	73.15	23.72	0.33	0.67
aorta, adult, pool1	10052-101G7	46.68	20.20	15.69	6.67	0.39	0.20
appendix, adult	10189-103D9	79.18	19.79	22.12	4.27	0.00	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	262.77	54.69	53.31	13.07	0.34	0.00
artery, adult	10190-103E1	250.00	46.20	57.06	17.66	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	75.62	33.32	29.99	9.71	0.00	0.00
b cell line:RPMI1788	10427-106D4	89.52	31.08	20.22	11.45	0.00	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	109.59	33.29	31.91	7.77	1.39	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	110.25	17.46	18.75	5.26	0.20	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	0.00	0.00	0.00	0.00	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	65.99	24.05	22.93	11.18	0.00	0.00
bladder, adult, pool1	10011-101C2	70.07	19.88	26.40	6.19	0.65	0.11
blood, adult, pool1	10053-101G8	66.44	15.50	13.29	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	36.82	18.84	17.13	0.86	0.00	0.86
bone marrow, adult	10192-103E3	79.63	11.47	18.90	3.37	0.67	1.35
brain, adult, donor1	10084-102B3	227.57	48.18	53.30	12.30	0.00	3.08
brain, adult, pool1	10012-101C3	177.17	55.01	53.45	18.71	1.34	0.45
brain, fetal, pool1	10085-102B4	176.31	93.50	66.78	53.43	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	179.72	16.85	30.06	3.63	0.66	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	435.51	29.71	44.06	4.37	0.25	0.50
breast, adult, donor1	10080-102A8	73.24	17.68	20.20	5.68	0.63	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	247.09	9.27	11.69	2.54	0.25	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	162.96	12.06	20.72	3.09	0.00	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	26.24	14.27	11.51	6.22	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	149.37	15.01	14.28	4.12	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	296.68	37.14	41.84	8.93	0.94	0.00
carcinoid cell line:NCI-H727	10735-110B6	337.66	28.77	39.60	7.22	0.66	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	189.50	52.92	38.34	13.94	0.63	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	387.82	51.37	76.39	8.78	1.33	1.06
caudate nucleus - adult, donor10196	10177-103C6	115.13	23.03	26.48	4.61	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	139.55	49.36	45.18	11.04	0.50	0.50
caudate nucleus, adult, donor10258	10379-105H1	119.97	27.51	48.90	22.16	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	116.10	26.74	28.20	12.82	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	174.80	52.44	49.53	8.74	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	147.96	41.42	46.12	12.38	0.21	0.00
cerebellum, adult, pool1	10083-102B2	185.24	49.33	46.91	14.14	0.34	1.38
cerebellum, newborn, donor10223	10357-105E6	191.80	24.08	34.04	9.13	0.83	0.83
cerebral meninges, adult	10188-103D8	190.87	61.27	57.49	21.18	0.76	0.00
cerebrospinal fluid, donor2	10294-104G6	91.36	19.00	23.39	6.58	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	235.95	64.85	72.61	11.07	0.58	0.00
cervical cancer cell line:ME-180	10553-107I4	245.76	20.71	31.15	3.65	0.00	0.17
cervix, adult, pool1	10013-101C4	91.03	24.67	29.50	9.66	0.94	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	0.28	0.00	0.00	0.14	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	14.37	11.76	6.53	3.92	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	290.06	27.96	41.88	11.31	4.47	0.50
choriocarcinoma cell line:SCH	10785-110H2	225.97	13.55	17.74	5.67	0.12	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	50.52	7.83	8.30	2.37	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	75.22	20.80	15.10	5.41	0.57	0.00
chorionic membrane cells, donor2	12239-129G7	134.83	36.39	36.49	8.35	2.98	0.10
chorionic membrane cells, donor3	12240-129G8	95.61	14.29	14.29	6.59	0.55	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	193.88	12.12	31.30	7.07	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	145.99	35.35	40.92	9.60	0.38	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	60.19	23.02	19.64	9.29	0.63	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	150.74	42.12	31.59	9.76	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	157.70	45.23	38.46	12.82	0.24	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	135.20	33.60	29.73	10.18	0.00	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	470.83	64.19	71.85	13.54	0.29	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	187.65	41.70	43.52	9.64	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	134.41	71.32	42.52	44.80	2.97	1.14
clear cell carcinoma cell line:TEN	10636-108I6	174.72	16.83	27.93	5.73	0.52	0.00
colon carcinoma cell line:CACO-2	10513-107D9	194.57	24.53	25.99	7.69	0.18	0.00
colon carcinoma cell line:COLO-320	10420-106C6	170.28	62.33	71.46	24.33	0.76	0.38
colon, adult, donor1	10082-102B1	158.27	30.94	38.08	9.52	0.00	0.00
colon, adult, pool1	10014-101C5	186.13	24.79	37.25	3.88	2.94	0.00
colon, fetal, donor1	10070-101I7	76.01	15.45	21.63	3.09	0.62	1.24
common myeloid progenitor CMP, donor1	12130-128D6	4.58	4.58	9.17	18.33	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	25.04	0.00	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	173.37	14.02	21.67	3.82	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	245.11	26.56	32.00	7.55	1.21	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	271.31	35.96	39.77	10.86	0.14	0.00
corpus callosum, adult, pool1	10042-101F6	126.48	38.03	39.91	13.60	0.22	0.22
cruciate ligament, donor2	10295-104G7	47.82	4.05	8.92	2.43	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	212.68	29.69	20.06	8.83	0.00	0.00
diencephalon, adult	10193-103E4	196.31	29.76	32.40	12.24	1.44	1.20
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	228.23	54.19	66.59	16.07	0.46	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	64.88	10.00	7.18	5.13	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	90.27	22.15	12.52	3.61	0.24	0.00
ductus deferens, adult	10196-103E7	175.42	28.41	35.88	11.46	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	92.17	23.04	17.28	7.20	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	91.96	22.81	31.63	10.30	0.00	0.00
dura mater, adult, donor1	10041-101F5	74.74	19.08	20.07	3.88	0.33	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	406.39	51.30	61.96	15.99	7.77	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	396.92	76.52	80.82	29.52	2.15	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	0.00	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	0.00	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	0.00	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	0.00	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	17.43	7.71	6.70	2.35	0.00	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	27.19	21.39	11.06	12.87	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	271.77	25.57	36.02	9.49	0.96	0.80
epidermoid carcinoma cell line:A431	10426-106D3	57.14	15.01	13.56	3.00	0.11	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	6.71	1.87	1.87	0.88	0.00	0.00
epididymis, adult	10197-103E8	124.96	33.49	32.65	8.37	2.09	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	0.18	0.00	0.00	0.00	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	27.92	3.15	3.93	1.57	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	353.70	41.80	43.51	9.96	0.66	0.52
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	260.12	34.15	39.66	9.35	0.59	0.49
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	314.13	46.04	47.39	10.42	1.01	1.12
esophagus, adult, pool1	10015-101C6	171.16	22.62	32.17	4.78	1.91	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	58.99	24.42	17.91	6.51	0.13	0.38
eye - muscle inferior rectus, donor1	10272-104E2	70.02	9.66	19.32	4.83	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	176.75	14.73	12.63	14.73	0.00	0.00
eye - muscle medial, donor2	10299-104H2	108.64	16.37	22.32	2.98	0.00	0.00
eye - muscle superior, donor2	10297-104G9	122.68	17.20	14.90	4.59	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	45.18	7.29	4.37	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	160.93	31.02	37.63	9.66	0.25	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	21.03	13.46	6.28	5.26	0.26	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	34.43	13.53	9.73	3.80	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	191.49	68.96	53.67	19.80	0.19	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	113.19	16.81	15.91	4.80	0.60	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	8.23	8.60	5.21	2.38	0.00	0.00
gall bladder, adult	10198-103E9	127.72	31.87	34.28	8.69	2.17	0.00
gamma delta positive T cells, donor1	11937-126A2	77.31	34.90	27.38	10.74	1.07	0.54
gamma delta positive T cells, donor2	11938-126A3	44.82	20.17	20.54	7.47	0.37	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	156.51	15.84	23.87	5.28	0.84	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	159.57	19.92	24.76	4.06	0.19	0.19
gastric cancer cell line:AZ521	10549-107H9	75.58	50.66	25.41	22.46	0.16	0.00
gastric cancer cell line:GSS	10560-108A2	57.66	26.54	25.63	23.80	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	303.62	28.10	26.96	13.48	0.69	0.69
giant cell carcinoma cell line:LU65	10487-107B1	48.08	23.41	16.29	3.90	0.11	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	81.04	18.75	25.89	5.32	0.28	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	61.11	5.74	7.98	1.75	0.25	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	0.00	0.00	0.00	0.00	0.00	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	0.00	0.00	0.00	0.00	0.00	0.00
glioblastoma cell line:T98G	10485-107A8	31.90	22.07	17.00	7.95	0.00	0.22
glioma cell line:GI-1	10413-106B8	63.26	24.31	24.02	6.44	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	130.48	33.53	25.51	10.93	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	126.44	31.24	36.86	6.83	0.24	0.00
globus pallidus, adult, donor10258	10367-105F7	109.54	19.17	30.12	5.48	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	97.52	25.58	21.85	15.99	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	9.79	4.89	2.45	4.89	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	65.57	32.79	21.86	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	57.49	10.45	15.68	5.23	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	63.36	22.40	27.52	5.76	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	84.94	41.32	30.76	6.43	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	92.37	34.75	30.64	9.15	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	65.05	39.29	24.48	8.37	0.00	0.00
hIPS, biol_rep1	14380-156B6	30.18	11.50	11.50	5.75	0.00	0.00
hIPS, biol_rep2	14381-156B7	41.15	19.20	15.77	6.86	0.00	0.00
hIPS, biol_rep3	14382-156B8	180.97	35.31	25.38	7.72	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	151.43	30.46	29.88	12.36	0.57	0.00
heart - mitral valve, adult	10205-103F7	126.46	29.00	28.40	8.37	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	216.76	39.48	38.70	13.60	0.00	0.78
heart - tricuspid valve, adult	10207-103F9	49.13	10.82	11.66	0.83	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	220.38	45.30	46.12	10.81	0.20	0.61
heart, adult, diseased, donor1	10051-101G6	465.01	69.84	91.98	22.57	2.13	1.28
heart, adult, pool1	10016-101C7	278.50	43.70	46.23	14.95	1.84	0.46
heart, fetal, pool1	10046-101G1	325.50	98.16	78.76	21.77	0.92	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	36.71	20.36	14.81	4.01	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	96.32	9.51	21.41	2.38	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	251.93	35.14	33.70	8.62	0.44	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	275.64	37.63	39.08	7.40	1.21	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	276.89	37.49	37.59	6.77	0.61	0.20
hepatoma cell line:Li-7	10484-107A7	90.42	29.92	23.36	4.11	0.56	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	185.62	33.17	27.44	8.84	0.10	0.00
hippocampus - adult, donor10196	10169-103B7	128.70	45.42	36.91	4.73	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	117.15	34.08	39.60	10.61	0.41	0.20
hippocampus, adult, donor10258	10374-105G5	76.68	22.91	20.91	6.47	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	82.48	38.07	32.78	14.80	1.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	264.89	78.73	105.59	25.02	3.05	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	165.53	67.94	48.89	25.72	1.96	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	193.98	71.85	52.05	29.20	2.79	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	163.52	112.21	133.64	37.22	7.33	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	222.32	129.36	146.41	46.48	13.69	7.75
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	200.43	129.83	145.39	52.77	8.73	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	206.70	78.24	99.85	36.79	12.55	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	201.43	102.11	110.95	42.22	17.88	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	195.61	97.18	89.25	40.87	12.93	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	431.91	125.74	115.55	32.91	7.81	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	341.36	105.43	120.06	36.48	13.02	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	370.99	129.95	95.61	24.24	10.77	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	174.17	66.98	53.52	23.79	1.72	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	196.52	70.75	52.57	26.53	2.95	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	292.37	65.46	77.68	25.31	5.24	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	227.57	137.46	133.64	44.29	7.45	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	218.47	115.12	111.63	40.99	5.67	2.18
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	260.38	120.44	144.43	35.48	4.50	3.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	133.57	84.59	87.79	34.29	8.10	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	167.34	97.31	77.76	26.37	10.00	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	124.35	81.44	82.69	34.14	4.70	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	240.38	97.16	85.90	30.86	8.33	1.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	238.05	81.87	81.29	25.26	8.71	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	187.13	83.10	91.77	29.59	4.48	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	209.50	69.65	60.04	22.72	3.51	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	195.42	69.89	47.36	25.39	1.71	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	276.84	72.68	80.44	23.27	4.49	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	273.92	97.53	100.34	28.52	11.27	2.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	237.24	97.56	82.35	38.01	9.19	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	270.54	112.57	123.77	46.60	8.47	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	216.67	95.15	100.84	24.30	7.24	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	212.53	97.63	89.00	35.20	9.96	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	190.35	85.43	90.04	30.78	10.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	243.12	79.00	85.90	19.68	9.97	2.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	286.99	93.90	101.47	37.86	11.36	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	187.52	69.23	73.26	21.17	4.37	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	200.21	74.87	53.13	23.18	3.62	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	199.21	68.63	65.07	22.73	5.79	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	186.83	73.17	60.98	20.49	1.95	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	215.77	99.63	118.89	46.76	10.39	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	279.78	172.42	250.50	22.77	32.53	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	321.34	144.29	155.54	45.67	13.57	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	267.08	110.01	111.65	39.95	9.85	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	196.14	98.07	99.52	31.85	14.11	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	219.93	91.81	95.37	37.37	10.32	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	284.03	66.83	95.47	34.61	9.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	339.24	125.00	106.04	31.01	7.18	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	227.37	68.43	80.55	23.17	4.85	0.54
immature langerhans cells, donor1	11904-125F5	4.36	1.45	0.73	0.48	0.00	0.00
immature langerhans cells, donor2	11905-125F6	12.67	2.38	0.00	1.58	0.00	0.00
insula, adult, pool1	10039-101F3	213.87	80.53	62.17	21.39	0.28	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	172.98	27.64	26.34	5.20	0.00	0.33
kidney, adult, pool1	10017-101C8	180.03	31.24	33.94	7.61	0.50	0.40
kidney, fetal, pool1	10045-101F9	194.03	47.04	50.29	12.73	0.07	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	36.64	13.35	10.65	3.69	0.00	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	98.29	24.75	23.64	9.12	0.14	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	47.71	7.89	7.16	3.67	0.00	0.00
left atrium, adult, donor1	10079-102A7	224.48	44.68	33.24	15.80	1.09	0.54
left ventricle, adult, donor1	10078-102A6	243.73	39.44	34.89	11.63	2.53	0.00
leiomyoblastoma cell line:G-402	10721-110A1	16.42	4.65	3.28	0.55	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	203.69	33.41	37.36	6.47	5.03	1.08
leiomyoma cell line:15242A	10570-108B3	139.67	24.46	29.35	7.61	1.63	0.54
leiomyoma cell line:15425	10571-108B4	130.39	23.80	36.91	8.50	1.21	1.21
leiomyosarcoma cell line:Hs 5.T	10722-110A2	101.59	19.05	19.05	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	70.05	21.96	31.37	3.14	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	0.24	0.47	0.12	0.12	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	77.32	27.65	25.31	5.94	0.31	0.47
liposarcoma cell line:SW 872	10726-110A6	35.70	18.40	14.86	5.36	0.00	0.00
liver, adult, pool1	10018-101C9	265.94	33.38	33.22	8.59	4.86	0.00
liver, fetal, pool1	10086-102B5	712.12	28.22	33.87	5.64	0.94	1.88
locus coeruleus - adult, donor10196	10182-103D2	212.47	26.10	34.12	9.19	0.29	0.00
locus coeruleus, adult, donor10252	10165-103B3	165.91	32.30	36.73	7.20	0.18	0.37
locus coeruleus, adult, donor10258	10375-105G6	292.01	36.68	46.83	19.19	2.26	1.97
locus coeruleus, newborn, donor10223	10362-105F2	172.03	21.03	39.54	8.41	0.84	0.42
lung adenocarcinoma cell line:A549	10499-107C4	0.00	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	82.73	19.99	25.51	9.65	0.00	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	23.07	10.55	8.70	4.75	0.13	0.40
lung, adult, pool1	10019-101D1	66.15	15.71	17.96	4.96	1.30	0.00
lung, fetal, donor1	10068-101I5	251.73	19.69	20.83	7.42	0.29	0.00
lung, right lower lobe, adult, donor1	10075-102A3	45.82	16.04	14.20	5.50	0.46	0.46
lymph node, adult, donor1	10077-102A5	40.24	11.83	12.31	1.89	1.42	0.00
lymphangiectasia cell line:DS-1	10727-110A7	49.97	14.47	13.59	6.36	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	31.09	13.28	13.43	4.08	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	33.98	5.10	11.04	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	240.64	22.64	32.86	5.33	0.44	1.33
mature adipocyte, donor2	12232-129F9	310.67	24.28	32.58	3.74	1.45	0.00
mature adipocyte, donor3	12233-129G1	276.89	25.13	28.92	8.53	1.90	0.24
mature adipocyte, donor4	12234-129G2	284.54	20.53	35.27	4.47	1.32	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	70.76	26.92	18.82	6.67	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	174.84	63.17	47.38	11.28	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	135.54	41.75	47.26	9.56	0.37	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	181.72	48.29	51.47	13.66	0.32	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	152.26	48.62	58.43	12.37	0.00	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	173.31	48.26	63.79	17.38	0.68	3.04
medial temporal gyrus, adult, donor10252	10156-103A3	133.06	36.50	44.78	10.82	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	113.65	30.82	25.04	11.56	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	57.41	43.06	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	155.78	67.12	44.87	16.87	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	133.69	31.80	29.20	10.38	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	138.39	31.12	34.68	8.20	0.15	0.00
medulla oblongata, adult, pool1	10038-101F2	216.23	35.83	36.24	11.59	0.08	0.16
medulla oblongata, newborn, donor10223	10361-105F1	130.19	25.69	25.34	9.72	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	134.18	38.97	42.73	9.74	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	107.23	35.46	26.53	11.13	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	25.01	11.64	7.62	3.31	0.00	0.00
melanoma cell line:G-361	10465-106H6	35.29	28.23	12.49	7.33	1.09	0.27
meningioma cell line:HKBMM	10691-109F7	65.49	27.32	28.94	5.25	0.36	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	860.01	53.75	106.62	14.10	5.29	4.41
merkel cell carcinoma cell line:MS-1	10844-111E7	583.25	68.43	83.73	20.74	2.33	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	56.16	22.71	17.34	5.98	0.46	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	34.90	18.72	13.82	7.82	0.00	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	52.59	14.49	12.42	8.70	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	66.30	15.87	14.33	6.46	0.14	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	76.06	22.34	20.22	8.67	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	61.77	21.52	22.90	3.47	1.39	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	75.86	18.71	22.31	7.38	0.86	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	48.88	18.86	11.96	6.90	0.12	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	90.06	29.84	20.69	8.36	0.13	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	86.97	25.39	22.15	8.64	0.27	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	91.33	20.49	18.92	7.68	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	43.47	17.46	13.83	4.61	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	81.09	25.60	24.49	8.30	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	66.33	17.45	19.20	8.38	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	66.56	28.58	16.33	8.57	0.00	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	63.26	22.29	19.41	7.19	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	49.76	24.10	15.00	8.38	0.41	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	83.22	17.56	20.52	4.56	0.23	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	68.39	16.78	15.94	4.20	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	98.93	31.23	27.94	9.71	0.15	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	73.09	23.20	20.83	8.32	0.09	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	47.86	20.99	24.30	9.20	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	80.41	25.75	23.18	4.86	0.86	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	45.47	12.21	13.89	8.00	0.84	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	67.59	23.75	19.18	5.94	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	61.64	15.86	18.16	5.88	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	61.51	23.03	19.37	6.02	0.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	65.01	20.64	17.87	6.16	0.31	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	57.66	20.24	20.48	5.18	0.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	53.48	23.02	19.97	6.77	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	60.91	20.04	18.47	7.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	62.09	15.29	19.46	9.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	70.66	20.77	24.80	8.94	0.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	62.69	20.97	17.62	4.91	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	61.53	20.19	18.99	6.25	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	44.00	19.80	19.07	3.67	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	57.73	20.48	17.45	6.38	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	62.63	23.33	21.29	7.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	64.86	24.48	12.89	6.01	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	68.36	30.08	19.14	5.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	15.49	20.66	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	57.49	23.71	19.49	6.17	0.65	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	37.83	17.46	18.91	4.36	1.45	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	66.10	28.25	18.12	5.33	1.07	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	51.52	23.72	14.72	6.54	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	53.64	15.94	12.05	8.94	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	33.58	16.79	25.18	4.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	51.66	13.91	14.90	4.97	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	66.74	38.14	14.30	9.53	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	52.77	25.50	20.75	11.27	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	56.05	23.15	12.18	4.87	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	65.87	18.37	19.00	7.60	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	56.22	23.11	15.87	6.55	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	32.24	25.79	15.04	2.15	4.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	39.92	31.93	23.95	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	37.88	37.88	27.55	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	50.12	20.78	19.56	7.33	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	48.46	23.83	23.04	9.53	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	37.14	25.35	24.76	4.72	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	35.85	22.44	12.78	5.92	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	40.10	26.73	16.04	4.01	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	153.75	33.11	26.02	10.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	159.22	28.25	28.25	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	159.71	25.47	26.16	4.82	1.38	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	539.84	32.66	35.63	9.90	3.96	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	393.65	40.37	32.52	11.22	5.61	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	485.95	33.71	42.62	8.27	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	571.43	31.03	44.73	4.03	3.63	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	547.33	34.89	54.51	4.36	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	591.72	40.55	41.81	10.14	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	526.17	17.60	22.45	6.07	3.03	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	411.23	13.56	27.11	0.00	9.04	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	406.90	17.30	29.65	2.47	3.29	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	295.06	28.37	27.18	9.92	1.19	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	310.54	22.07	27.91	7.79	2.92	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	250.58	29.54	28.52	8.15	3.06	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	3.09	0.77	1.55	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	44.18	28.82	12.76	7.09	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	44.71	19.23	9.50	5.10	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	6.58	3.49	2.67	1.03	0.00	0.00
mesothelioma cell line:Mero-25	10850-111F4	36.54	7.49	9.99	2.27	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	95.59	38.63	35.45	18.34	0.00	0.49
mesothelioma cell line:Mero-48a	10852-111F6	67.09	24.58	22.36	5.76	0.22	0.00
mesothelioma cell line:Mero-82	10853-111F7	25.75	12.09	6.83	3.68	0.26	0.00
mesothelioma cell line:Mero-83	10854-111F8	34.73	11.58	13.28	3.92	0.00	0.00
mesothelioma cell line:Mero-84	10855-111F9	38.67	16.94	12.89	6.32	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	166.88	29.61	36.44	8.70	1.04	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	107.84	27.33	24.85	10.93	0.17	0.00
mesothelioma cell line:NCI-H226	10846-111E9	10.32	5.61	5.61	2.17	0.00	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	44.07	12.64	17.08	7.17	0.17	0.17
mesothelioma cell line:NCI-H28	10845-111E8	0.00	0.25	0.25	0.00	0.00	0.00
mesothelioma cell line:No36	10857-111G2	29.68	11.42	9.46	3.91	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	96.19	12.73	20.59	2.98	0.27	0.27
migratory langerhans cells, donor1	11901-125F2	10.36	4.99	4.03	0.96	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	6.96	2.81	4.03	1.71	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	11.67	6.28	5.03	1.79	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	59.42	18.28	17.63	5.88	0.65	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	0.85	1.48	2.33	0.21	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	38.01	9.21	11.29	1.38	0.23	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	107.13	25.88	24.36	6.66	0.57	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	278.85	55.25	51.19	13.12	0.74	0.37
myeloma cell line:PCM6	10474-106I6	131.05	24.91	23.32	4.15	0.00	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	0.00	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	1.18	0.59	0.39	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	47.02	11.92	9.92	2.23	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	49.20	10.66	10.88	2.13	0.07	0.15
nasal epithelial cells, donor2	12227-129F4	41.40	19.87	7.18	3.86	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	157.82	78.22	46.70	19.56	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	457.80	176.61	158.27	28.62	0.19	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	263.40	50.82	62.21	10.33	0.63	0.21
neuroblastoma cell line:NH-12	10555-107I6	185.05	64.85	56.65	21.62	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	155.62	24.67	45.07	7.12	0.71	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	207.64	26.45	45.93	6.81	1.27	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	196.83	42.06	46.29	12.48	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	99.82	22.25	30.52	9.54	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	44.98	20.76	14.11	6.12	0.00	0.00
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	163.37	52.43	62.41	14.38	0.51	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	600.38	102.46	131.28	28.82	3.20	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	80.47	29.18	18.92	9.94	0.00	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	105.63	22.86	34.16	8.41	0.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	183.45	68.99	46.12	21.28	0.19	0.09
occipital cortex - adult, donor10196	10172-103C1	201.92	57.69	32.97	12.36	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	111.10	36.77	34.08	7.78	0.00	0.54
occipital cortex, newborn, donor10223	10355-105E4	147.40	59.32	60.41	24.38	0.36	0.00
occipital lobe, adult, donor1	10076-102A4	213.07	66.91	64.81	23.62	1.84	0.52
occipital lobe, fetal, donor1	10073-102A1	144.61	89.25	76.38	27.46	0.43	0.43
occipital pole, adult, pool1	10036-101E9	250.16	78.53	62.60	20.58	0.24	0.08
olfactory region, adult	10195-103E6	141.00	46.23	40.89	10.70	0.38	0.00
optic nerve, donor1	10277-104E7	42.02	18.01	34.02	4.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	241.71	25.97	25.06	6.49	1.03	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	150.58	35.17	31.74	9.62	0.14	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	20.83	6.43	9.65	1.86	0.00	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	44.01	9.47	11.78	2.19	0.12	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	23.52	10.58	7.64	4.41	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	30.83	14.02	13.08	3.74	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	113.03	26.72	23.33	9.33	0.42	0.00
ovary, adult, pool1	10020-101D2	96.87	29.70	33.19	7.69	0.70	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	35.93	15.58	12.10	2.75	0.00	0.00
pancreas, adult, donor1	10049-101G4	126.05	58.32	24.46	8.47	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	124.67	11.74	11.18	3.07	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	121.63	13.63	26.92	3.41	0.17	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	93.22	10.27	14.07	2.65	0.33	0.00
paracentral gyrus, adult, pool1	10035-101E8	253.88	74.77	57.48	20.59	0.37	0.09
parietal cortex, adult, donor10258	10373-105G4	148.27	35.97	27.16	6.61	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	138.25	46.08	38.56	7.52	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	144.23	39.62	43.33	6.56	0.86	0.00
parietal lobe, adult, pool1	10034-101E7	232.11	71.47	55.25	18.77	0.35	0.18
parietal lobe, fetal, donor1	10072-101I9	148.38	58.19	86.32	23.28	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	144.31	41.12	43.37	18.32	0.75	0.75
parotid gland, adult	10199-103F1	164.03	24.05	32.07	8.63	0.00	0.00
penis, adult	10200-103F2	104.20	22.02	33.30	8.06	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	103.57	13.76	18.22	4.09	0.19	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	76.20	9.76	10.34	2.48	0.00	0.15
pineal gland - adult, donor10196	10179-103C8	283.17	48.38	66.44	10.97	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	172.93	50.34	52.11	11.25	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	295.35	29.47	72.11	9.41	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	278.25	44.52	36.42	8.09	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	167.82	50.55	44.30	10.94	0.52	0.52
pituitary gland, adult, donor10258	10378-105G9	241.75	36.60	45.97	10.21	0.85	0.85
placenta, adult, pool1	10021-101D3	74.93	13.22	15.70	4.84	0.54	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	42.24	16.16	11.79	7.81	0.00	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	37.51	17.59	14.01	6.85	0.00	0.00
pons, adult, pool1	10033-101E6	332.39	47.34	39.25	12.39	0.09	0.00
postcentral gyrus, adult, pool1	10032-101E5	262.05	80.72	68.96	21.71	0.26	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	10.46	2.09	2.09	4.18	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	187.27	16.52	16.52	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	58.68	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	103.86	19.66	16.61	6.12	0.00	0.00
prostate cancer cell line:PC-3	10439-106E7	312.00	50.64	46.46	10.89	0.54	0.00
prostate, adult, pool1	10022-101D4	96.68	25.85	32.01	8.80	1.00	0.18
putamen, adult, donor10196	10176-103C5	164.06	64.68	51.70	18.41	0.00	0.47
putamen, adult, donor10252	10152-102I8	101.96	43.14	25.49	13.73	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	83.05	16.39	15.30	5.46	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	113.32	40.59	29.48	14.98	0.97	0.24
putamen, newborn, donor10223	10365-105F5	149.18	39.73	47.23	9.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	105.32	10.76	13.67	2.04	0.00	0.00
rectum, fetal, donor1	10067-101I4	57.03	31.99	22.26	18.08	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	47.70	30.32	17.17	14.63	0.00	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	16.57	24.44	10.36	4.97	0.00	0.00
retina, adult, pool1	10030-101E3	167.29	36.88	39.26	11.83	0.20	0.40
retinoblastoma cell line:Y79	10475-106I7	325.01	91.71	83.40	27.80	0.26	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	141.88	26.80	22.62	7.38	0.37	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	97.86	42.18	32.34	9.56	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	32.59	15.91	21.22	6.82	0.76	0.00
salivary acinar cells, donor1	11771-123I7	102.78	17.64	16.99	3.56	0.49	0.32
salivary acinar cells, donor2	11772-123I8	117.31	21.34	21.20	4.13	0.69	0.14
salivary acinar cells, donor3	11773-123I9	70.84	7.94	9.93	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	203.04	23.45	38.32	4.58	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	63.74	15.34	18.38	5.40	0.08	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	64.65	17.52	17.63	3.88	0.12	0.00
seminal vesicle, adult	10201-103F3	152.37	39.68	44.97	8.99	4.76	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	8.99	5.10	7.53	0.97	0.00	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	72.97	16.10	20.38	11.32	0.75	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	51.18	17.06	15.05	13.05	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	43.39	9.13	8.33	2.15	0.00	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	153.63	11.72	15.47	2.76	0.22	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	67.48	14.84	18.32	5.03	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	185.85	27.66	28.37	9.22	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	244.79	44.02	54.57	14.75	6.60	0.00
skeletal muscle, fetal, donor1	10066-101I3	107.54	33.17	33.17	24.12	1.01	0.00
skin, adult, donor1	10074-102A2	156.06	20.36	61.07	13.57	0.00	0.00
skin, fetal, donor1	10065-101I2	131.93	27.14	22.72	13.26	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	673.05	39.36	52.03	16.68	2.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	554.13	84.48	121.04	11.03	0.63	1.58
small cell lung carcinoma cell line:DMS 144	10841-111E4	19.47	20.24	10.60	13.11	0.00	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	198.78	32.64	52.25	9.23	0.49	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	153.93	79.46	55.17	31.04	0.48	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	144.04	14.82	21.57	4.58	0.44	0.00
small intestine, adult, pool1	10024-101D6	246.77	25.44	35.47	4.90	1.67	0.24
small intestine, fetal, donor1	10064-101I1	90.66	23.59	21.38	4.18	0.00	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	136.94	21.54	31.29	5.64	1.03	0.51
smooth muscle, adult, pool1	10048-101G3	67.97	21.97	22.49	4.65	0.00	0.26
somatostatinoma cell line:QGP-1	10781-110G7	133.47	42.88	39.40	6.97	0.27	0.27
spinal cord - adult, donor10196	10181-103D1	108.51	22.48	24.32	8.49	0.46	0.46
spinal cord, adult, donor10252	10159-103A6	97.78	19.32	24.44	9.07	0.39	0.39
spinal cord, adult, donor10258	10369-105F9	98.93	22.83	24.90	10.38	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	152.46	46.96	51.23	25.61	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	167.15	28.01	33.52	6.43	0.92	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	41.22	20.01	14.49	5.23	0.15	0.00
spleen, adult, pool1	10025-101D7	57.93	14.98	16.63	4.85	0.22	0.22
spleen, fetal, pool1	10044-101F8	198.80	20.42	23.28	6.12	0.24	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	31.99	14.28	9.94	3.00	0.00	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	30.19	7.78	4.94	2.47	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	148.52	27.26	23.06	7.34	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	33.23	11.73	11.34	2.35	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	109.97	18.12	18.35	3.26	0.00	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	94.89	17.79	21.60	15.67	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	45.27	8.46	11.00	5.92	0.00	0.00
stomach, fetal, donor1	10062-101H8	103.59	21.36	16.02	3.20	0.00	1.07
submaxillary gland, adult	10202-103F4	158.37	33.61	31.90	13.67	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27	0.00	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	111.75	31.78	36.14	6.02	0.42	0.00
substantia nigra, adult, donor10258	10371-105G2	189.31	27.93	26.38	9.83	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	115.88	11.31	19.78	6.36	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	214.59	71.07	50.44	29.58	1.15	0.23
temporal lobe, adult, pool1	10031-101E4	251.01	82.23	74.85	28.57	0.25	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	164.53	105.42	71.94	28.49	0.71	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	170.98	78.24	84.83	25.49	0.88	0.88
tenocyte, donor1	11763-123H8	63.19	26.18	15.36	10.47	1.05	0.35
tenocyte, donor2	11765-123I1	87.75	22.89	24.42	5.72	0.76	0.00
tenocyte, donor3	11768-123I4	56.71	20.76	16.31	6.30	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	110.47	32.29	25.83	9.18	0.17	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	75.38	24.36	19.27	6.78	0.62	0.15
teratocarcinoma cell line:PA-1	10807-111A6	76.25	34.72	22.01	8.37	0.00	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	144.47	40.37	30.59	9.52	1.27	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	85.85	18.53	13.24	5.67	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	151.05	29.23	22.47	6.87	0.33	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	77.19	17.26	12.05	3.91	0.98	0.33
testis, adult, pool1	10026-101D8	68.07	24.70	27.81	7.19	4.08	0.21
testis, adult, pool2	10096-102C6	28.42	7.22	8.12	3.16	0.00	0.00
thalamus - adult, donor10196	10168-103B6	176.64	33.12	35.33	4.42	0.00	0.00
thalamus, adult, donor10252	10154-103A1	108.93	26.88	34.07	5.78	0.16	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	183.21	16.94	27.71	10.78	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	297.92	33.76	42.98	14.00	0.82	0.99
thalamus, newborn, donor10223	10366-105F6	317.00	32.22	46.03	12.66	0.58	0.00
throat, adult	10209-103G2	197.24	30.46	36.45	9.49	1.50	0.75
throat, fetal, donor1	10061-101H7	117.62	25.60	28.34	7.62	0.30	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	440.59	71.54	82.47	25.64	0.79	0.60
thymus, adult, pool1	10027-101D9	148.63	26.34	46.82	10.84	3.08	0.10
thymus, fetal, pool1	10043-101F7	130.82	19.43	27.85	6.96	0.10	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	57.04	12.90	13.83	4.25	0.13	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	118.32	29.47	27.52	6.15	0.42	0.28
thyroid, adult, pool1	10028-101E1	150.14	33.03	39.84	9.52	0.84	0.09
thyroid, fetal, donor1	10060-101H6	109.68	30.85	26.89	8.17	0.26	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	76.99	12.32	12.32	3.08	0.00	0.00
tongue, adult	10203-103F5	252.11	35.82	42.10	10.47	2.79	0.93
tongue, fetal, donor1	10059-101H5	299.51	44.14	40.99	9.85	0.39	0.00
tonsil, adult, pool1	10047-101G2	141.85	26.45	26.55	6.51	0.10	0.00
trachea, adult, pool1	10029-101E2	87.03	19.63	20.45	5.32	0.49	0.08
trachea, fetal, donor1	10058-101H4	111.18	20.00	19.62	8.46	0.77	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	66.60	26.92	17.01	7.09	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	222.90	33.64	38.50	9.22	0.30	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	38.55	13.48	13.95	4.07	0.47	0.00
tridermal teratoma cell line:HGRT	10694-109G1	62.78	17.12	28.54	9.51	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	90.32	12.02	16.34	2.20	0.17	0.17
umbilical cord, fetal, donor1	10057-101H3	102.24	47.99	16.69	6.26	0.00	0.00
uterus, adult, pool1	10100-102D1	79.51	20.82	24.57	6.31	0.34	0.00
uterus, fetal, donor1	10055-101H1	104.95	32.25	28.67	13.31	0.00	0.00
vagina, adult	10204-103F6	47.82	18.74	10.99	3.23	0.00	0.00
vein, adult	10191-103E2	87.46	18.41	23.89	8.11	1.10	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	42.19	18.69	16.02	2.94	0.27	0.00